<?xml version="1.0" encoding="UTF-8"?>

<txns>
  <txn>
    <txnID>1001</txnID>
    <date>3/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1002</txnID>
    <date>9/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1003</txnID>
    <date>4/1/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1004</txnID>
    <date>10/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1005</txnID>
    <date>7/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1006</txnID>
    <date>9/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1007</txnID>
    <date>12/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1008</txnID>
    <date>2/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1009</txnID>
    <date>4/7/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1010</txnID>
    <date>6/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1011</txnID>
    <date>5/8/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1012</txnID>
    <date>8/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1013</txnID>
    <date>10/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1014</txnID>
    <date>5/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1015</txnID>
    <date>8/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1016</txnID>
    <date>4/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1017</txnID>
    <date>2/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1018</txnID>
    <date>3/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1019</txnID>
    <date>5/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1020</txnID>
    <date>10/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1021</txnID>
    <date>2/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1022</txnID>
    <date>6/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1023</txnID>
    <date>10/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1024</txnID>
    <date>2/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1025</txnID>
    <date>9/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1026</txnID>
    <date>2/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1027</txnID>
    <date>2/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1028</txnID>
    <date>7/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1029</txnID>
    <date>1/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1030</txnID>
    <date>12/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1031</txnID>
    <date>3/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1032</txnID>
    <date>2/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1033</txnID>
    <date>11/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1034</txnID>
    <date>3/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1035</txnID>
    <date>8/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1036</txnID>
    <date>6/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1037</txnID>
    <date>3/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1038</txnID>
    <date>6/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1039</txnID>
    <date>2/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1040</txnID>
    <date>8/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1041</txnID>
    <date>7/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1042</txnID>
    <date>2/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1043</txnID>
    <date>7/1/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1044</txnID>
    <date>6/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1045</txnID>
    <date>9/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1046</txnID>
    <date>9/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1047</txnID>
    <date>10/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1048</txnID>
    <date>2/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1049</txnID>
    <date>9/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1050</txnID>
    <date>2/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1051</txnID>
    <date>9/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1052</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1053</txnID>
    <date>8/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1054</txnID>
    <date>5/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1055</txnID>
    <date>5/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1056</txnID>
    <date>9/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1057</txnID>
    <date>1/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1058</txnID>
    <date>4/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1059</txnID>
    <date>3/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1060</txnID>
    <date>6/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1061</txnID>
    <date>11/28/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1062</txnID>
    <date>4/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1063</txnID>
    <date>10/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1064</txnID>
    <date>3/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1065</txnID>
    <date>6/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1066</txnID>
    <date>8/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1067</txnID>
    <date>4/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1068</txnID>
    <date>2/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1069</txnID>
    <date>3/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1070</txnID>
    <date>2/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1071</txnID>
    <date>2/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1072</txnID>
    <date>5/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1073</txnID>
    <date>2/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1074</txnID>
    <date>3/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1075</txnID>
    <date>1/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1076</txnID>
    <date>11/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1077</txnID>
    <date>8/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1078</txnID>
    <date>10/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1079</txnID>
    <date>7/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1080</txnID>
    <date>10/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1081</txnID>
    <date>5/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1082</txnID>
    <date>12/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1083</txnID>
    <date>3/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1084</txnID>
    <date>3/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1085</txnID>
    <date>2/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1086</txnID>
    <date>4/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1087</txnID>
    <date>4/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1088</txnID>
    <date>4/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1089</txnID>
    <date>10/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1090</txnID>
    <date>2/28/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1091</txnID>
    <date>11/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1092</txnID>
    <date>5/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1093</txnID>
    <date>9/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1094</txnID>
    <date>5/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1095</txnID>
    <date>2/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1096</txnID>
    <date>6/10/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1097</txnID>
    <date>12/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1098</txnID>
    <date>2/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1099</txnID>
    <date>4/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1100</txnID>
    <date>9/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1101</txnID>
    <date>11/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1102</txnID>
    <date>4/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1103</txnID>
    <date>7/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1104</txnID>
    <date>6/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1105</txnID>
    <date>2/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1106</txnID>
    <date>11/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1107</txnID>
    <date>8/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1108</txnID>
    <date>4/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1109</txnID>
    <date>10/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1110</txnID>
    <date>2/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1111</txnID>
    <date>9/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1112</txnID>
    <date>12/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1113</txnID>
    <date>11/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1114</txnID>
    <date>9/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1115</txnID>
    <date>10/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1116</txnID>
    <date>5/7/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1117</txnID>
    <date>8/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1118</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1119</txnID>
    <date>8/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1120</txnID>
    <date>2/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1121</txnID>
    <date>4/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1122</txnID>
    <date>4/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1123</txnID>
    <date>5/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1124</txnID>
    <date>10/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1125</txnID>
    <date>10/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1126</txnID>
    <date>1/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1127</txnID>
    <date>3/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1128</txnID>
    <date>11/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1129</txnID>
    <date>2/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1130</txnID>
    <date>11/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1131</txnID>
    <date>6/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1132</txnID>
    <date>7/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1133</txnID>
    <date>4/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1134</txnID>
    <date>4/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1135</txnID>
    <date>11/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1136</txnID>
    <date>9/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1137</txnID>
    <date>11/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1138</txnID>
    <date>6/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1139</txnID>
    <date>1/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1140</txnID>
    <date>9/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1141</txnID>
    <date>4/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1142</txnID>
    <date>10/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1143</txnID>
    <date>9/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1144</txnID>
    <date>5/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1145</txnID>
    <date>8/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1146</txnID>
    <date>8/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1147</txnID>
    <date>10/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1148</txnID>
    <date>3/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1149</txnID>
    <date>5/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1150</txnID>
    <date>12/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1151</txnID>
    <date>3/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1152</txnID>
    <date>7/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1153</txnID>
    <date>11/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1154</txnID>
    <date>8/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1155</txnID>
    <date>6/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1156</txnID>
    <date>2/23/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1157</txnID>
    <date>11/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1158</txnID>
    <date>5/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1159</txnID>
    <date>9/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1160</txnID>
    <date>2/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1161</txnID>
    <date>5/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1162</txnID>
    <date>10/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1163</txnID>
    <date>8/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1164</txnID>
    <date>4/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1165</txnID>
    <date>2/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1166</txnID>
    <date>7/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1167</txnID>
    <date>11/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1168</txnID>
    <date>8/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1169</txnID>
    <date>3/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1170</txnID>
    <date>4/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1171</txnID>
    <date>10/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1172</txnID>
    <date>9/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1173</txnID>
    <date>8/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1174</txnID>
    <date>12/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1175</txnID>
    <date>5/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1176</txnID>
    <date>5/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1177</txnID>
    <date>2/25/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1178</txnID>
    <date>2/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1179</txnID>
    <date>3/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1180</txnID>
    <date>1/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1181</txnID>
    <date>10/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1182</txnID>
    <date>2/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1183</txnID>
    <date>2/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1184</txnID>
    <date>6/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1185</txnID>
    <date>9/2/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1186</txnID>
    <date>10/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1187</txnID>
    <date>5/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1188</txnID>
    <date>3/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1189</txnID>
    <date>11/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1190</txnID>
    <date>10/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1191</txnID>
    <date>7/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1192</txnID>
    <date>8/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1193</txnID>
    <date>8/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1194</txnID>
    <date>1/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1195</txnID>
    <date>9/2/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1196</txnID>
    <date>9/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1197</txnID>
    <date>9/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1198</txnID>
    <date>6/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1199</txnID>
    <date>9/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1200</txnID>
    <date>3/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1201</txnID>
    <date>3/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1202</txnID>
    <date>7/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1203</txnID>
    <date>7/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1204</txnID>
    <date>9/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1205</txnID>
    <date>11/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1206</txnID>
    <date>6/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1207</txnID>
    <date>5/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1208</txnID>
    <date>9/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1209</txnID>
    <date>7/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1210</txnID>
    <date>10/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1211</txnID>
    <date>8/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1212</txnID>
    <date>8/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1213</txnID>
    <date>12/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1214</txnID>
    <date>10/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1215</txnID>
    <date>1/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1216</txnID>
    <date>11/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1217</txnID>
    <date>9/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1218</txnID>
    <date>4/1/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1219</txnID>
    <date>5/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1220</txnID>
    <date>1/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1221</txnID>
    <date>10/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1222</txnID>
    <date>10/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1223</txnID>
    <date>5/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1224</txnID>
    <date>6/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1225</txnID>
    <date>6/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1226</txnID>
    <date>12/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1227</txnID>
    <date>7/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1228</txnID>
    <date>8/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1229</txnID>
    <date>9/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1230</txnID>
    <date>9/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1231</txnID>
    <date>4/28/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1232</txnID>
    <date>12/16/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1233</txnID>
    <date>6/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1234</txnID>
    <date>2/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1235</txnID>
    <date>2/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1236</txnID>
    <date>3/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1237</txnID>
    <date>10/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1238</txnID>
    <date>2/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1239</txnID>
    <date>4/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1240</txnID>
    <date>11/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1241</txnID>
    <date>3/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1242</txnID>
    <date>8/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1243</txnID>
    <date>12/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1244</txnID>
    <date>9/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1245</txnID>
    <date>10/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1246</txnID>
    <date>11/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1247</txnID>
    <date>4/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1248</txnID>
    <date>2/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1249</txnID>
    <date>6/1/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1250</txnID>
    <date>4/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1251</txnID>
    <date>8/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1252</txnID>
    <date>1/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1253</txnID>
    <date>9/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1254</txnID>
    <date>9/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1255</txnID>
    <date>8/28/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1256</txnID>
    <date>9/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1257</txnID>
    <date>6/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1258</txnID>
    <date>8/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1259</txnID>
    <date>8/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1260</txnID>
    <date>5/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1261</txnID>
    <date>10/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1262</txnID>
    <date>11/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1263</txnID>
    <date>9/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1264</txnID>
    <date>8/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1265</txnID>
    <date>11/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1266</txnID>
    <date>9/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1267</txnID>
    <date>3/10/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1268</txnID>
    <date>7/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1269</txnID>
    <date>1/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1270</txnID>
    <date>10/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1271</txnID>
    <date>4/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1272</txnID>
    <date>3/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1273</txnID>
    <date>7/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1274</txnID>
    <date>10/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1275</txnID>
    <date>5/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1276</txnID>
    <date>2/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1277</txnID>
    <date>11/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1278</txnID>
    <date>3/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1279</txnID>
    <date>6/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1280</txnID>
    <date>12/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1281</txnID>
    <date>3/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1282</txnID>
    <date>6/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1283</txnID>
    <date>4/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1284</txnID>
    <date>5/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1285</txnID>
    <date>6/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1286</txnID>
    <date>11/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1287</txnID>
    <date>5/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1288</txnID>
    <date>5/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1289</txnID>
    <date>9/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1290</txnID>
    <date>6/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1291</txnID>
    <date>4/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1292</txnID>
    <date>5/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1293</txnID>
    <date>3/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1294</txnID>
    <date>2/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1295</txnID>
    <date>9/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1296</txnID>
    <date>5/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1297</txnID>
    <date>12/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1298</txnID>
    <date>5/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1299</txnID>
    <date>6/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1300</txnID>
    <date>5/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1301</txnID>
    <date>7/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1302</txnID>
    <date>9/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1303</txnID>
    <date>3/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1304</txnID>
    <date>9/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1305</txnID>
    <date>6/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1306</txnID>
    <date>2/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1307</txnID>
    <date>10/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1308</txnID>
    <date>10/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1309</txnID>
    <date>6/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1310</txnID>
    <date>8/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1311</txnID>
    <date>10/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1312</txnID>
    <date>1/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1313</txnID>
    <date>11/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1314</txnID>
    <date>8/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1315</txnID>
    <date>2/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1316</txnID>
    <date>1/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1317</txnID>
    <date>12/14/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1318</txnID>
    <date>10/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1319</txnID>
    <date>7/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1320</txnID>
    <date>11/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1321</txnID>
    <date>2/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1322</txnID>
    <date>4/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1323</txnID>
    <date>11/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1324</txnID>
    <date>8/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1325</txnID>
    <date>11/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1326</txnID>
    <date>2/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1327</txnID>
    <date>3/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1328</txnID>
    <date>2/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1329</txnID>
    <date>7/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1330</txnID>
    <date>3/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1331</txnID>
    <date>10/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1332</txnID>
    <date>7/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1333</txnID>
    <date>7/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1334</txnID>
    <date>2/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1335</txnID>
    <date>10/28/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1336</txnID>
    <date>2/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1337</txnID>
    <date>7/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1338</txnID>
    <date>9/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1339</txnID>
    <date>10/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1340</txnID>
    <date>6/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1341</txnID>
    <date>8/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1342</txnID>
    <date>11/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1343</txnID>
    <date>5/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1344</txnID>
    <date>11/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1345</txnID>
    <date>10/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1346</txnID>
    <date>2/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1347</txnID>
    <date>4/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1348</txnID>
    <date>2/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1349</txnID>
    <date>7/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1350</txnID>
    <date>4/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1351</txnID>
    <date>10/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1352</txnID>
    <date>10/15/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1353</txnID>
    <date>10/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1354</txnID>
    <date>7/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1355</txnID>
    <date>10/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1356</txnID>
    <date>9/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1357</txnID>
    <date>2/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1358</txnID>
    <date>11/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1359</txnID>
    <date>12/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1360</txnID>
    <date>1/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1361</txnID>
    <date>5/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1362</txnID>
    <date>3/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1363</txnID>
    <date>7/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1364</txnID>
    <date>11/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1365</txnID>
    <date>2/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1366</txnID>
    <date>11/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1367</txnID>
    <date>6/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1368</txnID>
    <date>4/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1369</txnID>
    <date>5/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1370</txnID>
    <date>5/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1371</txnID>
    <date>10/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1372</txnID>
    <date>2/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1373</txnID>
    <date>11/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1374</txnID>
    <date>10/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1375</txnID>
    <date>10/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1376</txnID>
    <date>2/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1377</txnID>
    <date>8/19/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1378</txnID>
    <date>3/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1379</txnID>
    <date>6/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1380</txnID>
    <date>10/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1381</txnID>
    <date>5/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1382</txnID>
    <date>10/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1383</txnID>
    <date>8/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1384</txnID>
    <date>5/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1385</txnID>
    <date>6/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1386</txnID>
    <date>2/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1387</txnID>
    <date>11/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1388</txnID>
    <date>8/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1389</txnID>
    <date>2/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1390</txnID>
    <date>2/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1391</txnID>
    <date>8/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1392</txnID>
    <date>4/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1393</txnID>
    <date>6/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1394</txnID>
    <date>11/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1395</txnID>
    <date>2/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1396</txnID>
    <date>6/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1397</txnID>
    <date>3/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1398</txnID>
    <date>3/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1399</txnID>
    <date>9/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1400</txnID>
    <date>2/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1401</txnID>
    <date>11/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1402</txnID>
    <date>1/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1403</txnID>
    <date>6/22/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1404</txnID>
    <date>12/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1405</txnID>
    <date>10/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1406</txnID>
    <date>2/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1407</txnID>
    <date>5/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1408</txnID>
    <date>8/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1409</txnID>
    <date>2/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1410</txnID>
    <date>2/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1411</txnID>
    <date>8/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1412</txnID>
    <date>4/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1413</txnID>
    <date>7/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1414</txnID>
    <date>6/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1415</txnID>
    <date>3/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1416</txnID>
    <date>4/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1417</txnID>
    <date>8/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1418</txnID>
    <date>2/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1419</txnID>
    <date>2/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1420</txnID>
    <date>5/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1421</txnID>
    <date>5/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1422</txnID>
    <date>11/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1423</txnID>
    <date>11/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1424</txnID>
    <date>2/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1425</txnID>
    <date>4/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1426</txnID>
    <date>10/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1427</txnID>
    <date>4/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1428</txnID>
    <date>4/28/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1429</txnID>
    <date>2/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1430</txnID>
    <date>4/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1431</txnID>
    <date>5/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1432</txnID>
    <date>8/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1433</txnID>
    <date>6/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1434</txnID>
    <date>8/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1435</txnID>
    <date>11/7/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1436</txnID>
    <date>10/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1437</txnID>
    <date>3/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1438</txnID>
    <date>3/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1439</txnID>
    <date>9/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1440</txnID>
    <date>6/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1441</txnID>
    <date>5/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1442</txnID>
    <date>6/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1443</txnID>
    <date>9/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1444</txnID>
    <date>7/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1445</txnID>
    <date>1/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1446</txnID>
    <date>5/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1447</txnID>
    <date>7/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1448</txnID>
    <date>6/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1449</txnID>
    <date>3/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1450</txnID>
    <date>6/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1451</txnID>
    <date>11/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1452</txnID>
    <date>10/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1453</txnID>
    <date>3/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1454</txnID>
    <date>6/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1455</txnID>
    <date>4/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1456</txnID>
    <date>6/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1457</txnID>
    <date>2/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1458</txnID>
    <date>5/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1459</txnID>
    <date>9/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1460</txnID>
    <date>4/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1461</txnID>
    <date>10/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1462</txnID>
    <date>7/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1463</txnID>
    <date>11/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1464</txnID>
    <date>7/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1465</txnID>
    <date>10/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1466</txnID>
    <date>10/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1467</txnID>
    <date>2/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1468</txnID>
    <date>5/28/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1469</txnID>
    <date>3/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1470</txnID>
    <date>10/1/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1471</txnID>
    <date>8/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1472</txnID>
    <date>4/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1473</txnID>
    <date>3/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1474</txnID>
    <date>7/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1475</txnID>
    <date>7/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1476</txnID>
    <date>6/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1477</txnID>
    <date>7/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1478</txnID>
    <date>9/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1479</txnID>
    <date>5/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1480</txnID>
    <date>4/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1481</txnID>
    <date>8/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1482</txnID>
    <date>6/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1483</txnID>
    <date>6/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1484</txnID>
    <date>11/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1485</txnID>
    <date>9/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1486</txnID>
    <date>8/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1487</txnID>
    <date>12/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1488</txnID>
    <date>1/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1489</txnID>
    <date>11/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1490</txnID>
    <date>2/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1491</txnID>
    <date>2/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1492</txnID>
    <date>8/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1493</txnID>
    <date>7/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1494</txnID>
    <date>12/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1495</txnID>
    <date>8/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1496</txnID>
    <date>7/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1497</txnID>
    <date>6/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1498</txnID>
    <date>1/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1499</txnID>
    <date>3/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1500</txnID>
    <date>4/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1501</txnID>
    <date>10/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1502</txnID>
    <date>6/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1503</txnID>
    <date>6/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1504</txnID>
    <date>9/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1505</txnID>
    <date>7/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1506</txnID>
    <date>3/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1507</txnID>
    <date>4/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1508</txnID>
    <date>6/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1509</txnID>
    <date>3/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1510</txnID>
    <date>8/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1511</txnID>
    <date>6/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1512</txnID>
    <date>5/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1513</txnID>
    <date>8/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1514</txnID>
    <date>6/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1515</txnID>
    <date>4/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1516</txnID>
    <date>5/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1517</txnID>
    <date>10/24/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1518</txnID>
    <date>3/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1519</txnID>
    <date>6/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1520</txnID>
    <date>8/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1521</txnID>
    <date>9/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1522</txnID>
    <date>9/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1523</txnID>
    <date>10/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1524</txnID>
    <date>11/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1525</txnID>
    <date>7/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1526</txnID>
    <date>11/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1527</txnID>
    <date>6/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1528</txnID>
    <date>10/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1529</txnID>
    <date>12/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1530</txnID>
    <date>7/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1531</txnID>
    <date>7/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1532</txnID>
    <date>12/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1533</txnID>
    <date>10/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1534</txnID>
    <date>3/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1535</txnID>
    <date>8/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1536</txnID>
    <date>9/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1537</txnID>
    <date>12/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1538</txnID>
    <date>10/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1539</txnID>
    <date>10/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1540</txnID>
    <date>2/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1541</txnID>
    <date>8/28/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1542</txnID>
    <date>1/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1543</txnID>
    <date>7/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1544</txnID>
    <date>1/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1545</txnID>
    <date>5/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1546</txnID>
    <date>4/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1547</txnID>
    <date>11/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1548</txnID>
    <date>12/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1549</txnID>
    <date>5/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1550</txnID>
    <date>10/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1551</txnID>
    <date>3/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1552</txnID>
    <date>11/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1553</txnID>
    <date>10/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1554</txnID>
    <date>9/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1555</txnID>
    <date>5/27/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1556</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1557</txnID>
    <date>2/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1558</txnID>
    <date>10/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1559</txnID>
    <date>12/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1560</txnID>
    <date>4/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1561</txnID>
    <date>3/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1562</txnID>
    <date>2/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1563</txnID>
    <date>7/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1564</txnID>
    <date>6/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1565</txnID>
    <date>6/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1566</txnID>
    <date>12/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1567</txnID>
    <date>5/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1568</txnID>
    <date>6/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1569</txnID>
    <date>6/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1570</txnID>
    <date>3/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1571</txnID>
    <date>10/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1572</txnID>
    <date>6/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1573</txnID>
    <date>7/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1574</txnID>
    <date>5/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1575</txnID>
    <date>11/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1576</txnID>
    <date>9/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1577</txnID>
    <date>6/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1578</txnID>
    <date>6/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1579</txnID>
    <date>10/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1580</txnID>
    <date>7/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1581</txnID>
    <date>9/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1582</txnID>
    <date>9/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1583</txnID>
    <date>7/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1584</txnID>
    <date>10/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1585</txnID>
    <date>8/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1586</txnID>
    <date>10/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1587</txnID>
    <date>11/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1588</txnID>
    <date>2/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1589</txnID>
    <date>10/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1590</txnID>
    <date>6/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1591</txnID>
    <date>7/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1592</txnID>
    <date>9/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1593</txnID>
    <date>2/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1594</txnID>
    <date>4/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1595</txnID>
    <date>4/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1596</txnID>
    <date>7/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1597</txnID>
    <date>9/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1598</txnID>
    <date>11/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1599</txnID>
    <date>9/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1600</txnID>
    <date>11/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1601</txnID>
    <date>7/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1602</txnID>
    <date>11/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1603</txnID>
    <date>3/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1604</txnID>
    <date>12/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1605</txnID>
    <date>11/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1606</txnID>
    <date>2/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1607</txnID>
    <date>8/12/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1608</txnID>
    <date>1/21/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1609</txnID>
    <date>3/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1610</txnID>
    <date>8/1/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1611</txnID>
    <date>6/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1612</txnID>
    <date>3/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1613</txnID>
    <date>1/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1614</txnID>
    <date>6/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1615</txnID>
    <date>5/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1616</txnID>
    <date>3/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1617</txnID>
    <date>2/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1618</txnID>
    <date>9/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1619</txnID>
    <date>11/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1620</txnID>
    <date>7/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1621</txnID>
    <date>12/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1622</txnID>
    <date>10/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1623</txnID>
    <date>8/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1624</txnID>
    <date>2/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1625</txnID>
    <date>8/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1626</txnID>
    <date>6/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1627</txnID>
    <date>4/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1628</txnID>
    <date>10/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1629</txnID>
    <date>4/12/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1630</txnID>
    <date>3/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1631</txnID>
    <date>5/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1632</txnID>
    <date>3/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1633</txnID>
    <date>6/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1634</txnID>
    <date>9/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1635</txnID>
    <date>3/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1636</txnID>
    <date>10/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1637</txnID>
    <date>7/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1638</txnID>
    <date>4/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1639</txnID>
    <date>3/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1640</txnID>
    <date>8/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1641</txnID>
    <date>8/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1642</txnID>
    <date>3/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1643</txnID>
    <date>3/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1644</txnID>
    <date>6/24/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1645</txnID>
    <date>11/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1646</txnID>
    <date>2/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1647</txnID>
    <date>12/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1648</txnID>
    <date>10/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1649</txnID>
    <date>12/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1650</txnID>
    <date>9/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1651</txnID>
    <date>2/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1652</txnID>
    <date>5/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1653</txnID>
    <date>2/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1654</txnID>
    <date>6/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1655</txnID>
    <date>6/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1656</txnID>
    <date>3/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1657</txnID>
    <date>2/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1658</txnID>
    <date>12/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1659</txnID>
    <date>11/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1660</txnID>
    <date>6/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1661</txnID>
    <date>9/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1662</txnID>
    <date>9/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1663</txnID>
    <date>7/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1664</txnID>
    <date>6/24/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1665</txnID>
    <date>11/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1666</txnID>
    <date>2/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1667</txnID>
    <date>2/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1668</txnID>
    <date>4/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1669</txnID>
    <date>8/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1670</txnID>
    <date>5/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1671</txnID>
    <date>2/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1672</txnID>
    <date>3/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1673</txnID>
    <date>5/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1674</txnID>
    <date>5/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1675</txnID>
    <date>5/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1676</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1677</txnID>
    <date>9/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1678</txnID>
    <date>9/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1679</txnID>
    <date>11/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1680</txnID>
    <date>7/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1681</txnID>
    <date>4/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1682</txnID>
    <date>3/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1683</txnID>
    <date>6/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1684</txnID>
    <date>11/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1685</txnID>
    <date>5/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1686</txnID>
    <date>7/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1687</txnID>
    <date>5/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1688</txnID>
    <date>12/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1689</txnID>
    <date>2/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1690</txnID>
    <date>10/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1691</txnID>
    <date>10/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1692</txnID>
    <date>3/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1693</txnID>
    <date>8/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1694</txnID>
    <date>4/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1695</txnID>
    <date>10/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1696</txnID>
    <date>5/1/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1697</txnID>
    <date>12/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1698</txnID>
    <date>4/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1699</txnID>
    <date>7/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1700</txnID>
    <date>6/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1701</txnID>
    <date>7/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1702</txnID>
    <date>7/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1703</txnID>
    <date>5/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1704</txnID>
    <date>8/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1705</txnID>
    <date>7/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1706</txnID>
    <date>5/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1707</txnID>
    <date>2/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1708</txnID>
    <date>11/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1709</txnID>
    <date>7/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1710</txnID>
    <date>3/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1711</txnID>
    <date>3/19/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1712</txnID>
    <date>5/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1713</txnID>
    <date>9/18/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1714</txnID>
    <date>2/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1715</txnID>
    <date>11/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1716</txnID>
    <date>6/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1717</txnID>
    <date>11/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1718</txnID>
    <date>1/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1719</txnID>
    <date>4/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1720</txnID>
    <date>8/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1721</txnID>
    <date>4/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1722</txnID>
    <date>8/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1723</txnID>
    <date>8/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1724</txnID>
    <date>12/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1725</txnID>
    <date>1/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1726</txnID>
    <date>1/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1727</txnID>
    <date>6/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1728</txnID>
    <date>8/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1729</txnID>
    <date>11/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1730</txnID>
    <date>5/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1731</txnID>
    <date>3/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1732</txnID>
    <date>10/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1733</txnID>
    <date>9/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1734</txnID>
    <date>11/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1735</txnID>
    <date>5/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1736</txnID>
    <date>6/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1737</txnID>
    <date>3/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1738</txnID>
    <date>11/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1739</txnID>
    <date>10/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1740</txnID>
    <date>10/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1741</txnID>
    <date>7/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1742</txnID>
    <date>2/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1743</txnID>
    <date>1/1/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1744</txnID>
    <date>5/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1745</txnID>
    <date>11/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1746</txnID>
    <date>5/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1747</txnID>
    <date>7/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1748</txnID>
    <date>3/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1749</txnID>
    <date>11/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1750</txnID>
    <date>4/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1751</txnID>
    <date>2/20/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1752</txnID>
    <date>10/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1753</txnID>
    <date>3/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1754</txnID>
    <date>6/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1755</txnID>
    <date>8/4/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1756</txnID>
    <date>9/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1757</txnID>
    <date>6/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1758</txnID>
    <date>5/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1759</txnID>
    <date>2/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1760</txnID>
    <date>8/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1761</txnID>
    <date>12/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1762</txnID>
    <date>2/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1763</txnID>
    <date>8/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1764</txnID>
    <date>1/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1765</txnID>
    <date>5/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1766</txnID>
    <date>3/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1767</txnID>
    <date>11/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1768</txnID>
    <date>8/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1769</txnID>
    <date>5/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1770</txnID>
    <date>4/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1771</txnID>
    <date>6/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1772</txnID>
    <date>3/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1773</txnID>
    <date>3/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1774</txnID>
    <date>10/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1775</txnID>
    <date>8/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1776</txnID>
    <date>8/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1777</txnID>
    <date>5/3/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1778</txnID>
    <date>1/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1779</txnID>
    <date>10/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1780</txnID>
    <date>3/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1781</txnID>
    <date>11/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1782</txnID>
    <date>7/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1783</txnID>
    <date>9/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1784</txnID>
    <date>1/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1785</txnID>
    <date>6/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1786</txnID>
    <date>10/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1787</txnID>
    <date>5/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1788</txnID>
    <date>2/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1789</txnID>
    <date>5/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1790</txnID>
    <date>12/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1791</txnID>
    <date>7/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1792</txnID>
    <date>1/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1793</txnID>
    <date>4/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1794</txnID>
    <date>7/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1795</txnID>
    <date>9/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1796</txnID>
    <date>4/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1797</txnID>
    <date>6/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1798</txnID>
    <date>1/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1799</txnID>
    <date>6/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1800</txnID>
    <date>8/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1801</txnID>
    <date>5/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1802</txnID>
    <date>11/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1803</txnID>
    <date>2/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1804</txnID>
    <date>8/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1805</txnID>
    <date>8/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1806</txnID>
    <date>4/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1807</txnID>
    <date>11/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1808</txnID>
    <date>3/27/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1809</txnID>
    <date>8/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1810</txnID>
    <date>3/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1811</txnID>
    <date>1/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1812</txnID>
    <date>2/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1813</txnID>
    <date>4/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1814</txnID>
    <date>7/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1815</txnID>
    <date>7/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1816</txnID>
    <date>8/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1817</txnID>
    <date>2/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1818</txnID>
    <date>2/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1819</txnID>
    <date>8/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1820</txnID>
    <date>1/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1821</txnID>
    <date>6/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1822</txnID>
    <date>7/6/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1823</txnID>
    <date>6/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1824</txnID>
    <date>12/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1825</txnID>
    <date>4/28/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1826</txnID>
    <date>5/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1827</txnID>
    <date>2/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1828</txnID>
    <date>10/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1829</txnID>
    <date>9/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1830</txnID>
    <date>8/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1831</txnID>
    <date>5/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1832</txnID>
    <date>1/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1833</txnID>
    <date>9/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1834</txnID>
    <date>3/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1835</txnID>
    <date>2/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1836</txnID>
    <date>5/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1837</txnID>
    <date>10/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1838</txnID>
    <date>8/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1839</txnID>
    <date>12/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1840</txnID>
    <date>10/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1841</txnID>
    <date>11/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1842</txnID>
    <date>9/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1843</txnID>
    <date>9/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1844</txnID>
    <date>11/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1845</txnID>
    <date>11/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1846</txnID>
    <date>6/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1847</txnID>
    <date>8/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1848</txnID>
    <date>12/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1849</txnID>
    <date>7/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1850</txnID>
    <date>3/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>2000</qty>
    <amount>7740</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1851</txnID>
    <date>11/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1852</txnID>
    <date>3/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1853</txnID>
    <date>10/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1854</txnID>
    <date>9/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1855</txnID>
    <date>6/12/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1856</txnID>
    <date>2/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1857</txnID>
    <date>5/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1858</txnID>
    <date>11/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1859</txnID>
    <date>12/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1860</txnID>
    <date>11/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1861</txnID>
    <date>10/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1862</txnID>
    <date>4/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1863</txnID>
    <date>10/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1864</txnID>
    <date>3/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1865</txnID>
    <date>4/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1866</txnID>
    <date>4/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1867</txnID>
    <date>10/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1868</txnID>
    <date>7/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1869</txnID>
    <date>4/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1870</txnID>
    <date>4/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1871</txnID>
    <date>8/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1872</txnID>
    <date>1/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1873</txnID>
    <date>8/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1874</txnID>
    <date>4/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1875</txnID>
    <date>4/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1876</txnID>
    <date>10/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1877</txnID>
    <date>10/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1878</txnID>
    <date>5/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1879</txnID>
    <date>3/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1880</txnID>
    <date>5/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1881</txnID>
    <date>5/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1882</txnID>
    <date>10/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1883</txnID>
    <date>3/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1884</txnID>
    <date>4/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1885</txnID>
    <date>2/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1886</txnID>
    <date>2/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1887</txnID>
    <date>10/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1888</txnID>
    <date>5/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1889</txnID>
    <date>2/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1890</txnID>
    <date>2/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1891</txnID>
    <date>7/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1892</txnID>
    <date>3/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1893</txnID>
    <date>11/13/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1894</txnID>
    <date>9/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1895</txnID>
    <date>10/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1896</txnID>
    <date>7/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1897</txnID>
    <date>11/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1898</txnID>
    <date>4/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1899</txnID>
    <date>4/13/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1900</txnID>
    <date>4/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1901</txnID>
    <date>6/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1902</txnID>
    <date>4/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1903</txnID>
    <date>9/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1904</txnID>
    <date>8/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1905</txnID>
    <date>2/28/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1906</txnID>
    <date>11/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1907</txnID>
    <date>9/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1908</txnID>
    <date>10/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1909</txnID>
    <date>4/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1910</txnID>
    <date>1/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1911</txnID>
    <date>5/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1912</txnID>
    <date>12/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1913</txnID>
    <date>9/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1914</txnID>
    <date>4/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1915</txnID>
    <date>6/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1916</txnID>
    <date>3/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1917</txnID>
    <date>10/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1918</txnID>
    <date>3/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1919</txnID>
    <date>2/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1920</txnID>
    <date>8/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1921</txnID>
    <date>10/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1922</txnID>
    <date>5/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1923</txnID>
    <date>7/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1924</txnID>
    <date>5/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1925</txnID>
    <date>6/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1926</txnID>
    <date>11/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1927</txnID>
    <date>7/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1928</txnID>
    <date>12/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1929</txnID>
    <date>12/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1930</txnID>
    <date>4/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1931</txnID>
    <date>8/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1932</txnID>
    <date>10/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1933</txnID>
    <date>9/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1934</txnID>
    <date>11/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1935</txnID>
    <date>4/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1936</txnID>
    <date>3/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1937</txnID>
    <date>9/5/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1938</txnID>
    <date>7/19/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1939</txnID>
    <date>11/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1940</txnID>
    <date>4/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1941</txnID>
    <date>4/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1942</txnID>
    <date>11/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1943</txnID>
    <date>9/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1944</txnID>
    <date>4/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1945</txnID>
    <date>4/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1946</txnID>
    <date>4/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1947</txnID>
    <date>12/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1948</txnID>
    <date>12/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1949</txnID>
    <date>6/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1950</txnID>
    <date>8/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1951</txnID>
    <date>7/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1952</txnID>
    <date>3/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1953</txnID>
    <date>6/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1954</txnID>
    <date>2/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1955</txnID>
    <date>5/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1956</txnID>
    <date>4/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1957</txnID>
    <date>3/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1958</txnID>
    <date>2/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1959</txnID>
    <date>4/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1960</txnID>
    <date>4/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1961</txnID>
    <date>7/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1962</txnID>
    <date>6/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1963</txnID>
    <date>1/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1964</txnID>
    <date>9/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1965</txnID>
    <date>6/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1966</txnID>
    <date>7/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1967</txnID>
    <date>10/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1968</txnID>
    <date>6/17/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1969</txnID>
    <date>9/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1970</txnID>
    <date>5/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1971</txnID>
    <date>2/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1972</txnID>
    <date>6/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>1973</txnID>
    <date>6/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1974</txnID>
    <date>8/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1975</txnID>
    <date>10/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1976</txnID>
    <date>5/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1977</txnID>
    <date>7/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1978</txnID>
    <date>3/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1979</txnID>
    <date>4/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1980</txnID>
    <date>11/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1981</txnID>
    <date>5/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1982</txnID>
    <date>11/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1983</txnID>
    <date>11/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1984</txnID>
    <date>10/12/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1985</txnID>
    <date>8/28/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1986</txnID>
    <date>7/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1987</txnID>
    <date>1/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1988</txnID>
    <date>9/3/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1989</txnID>
    <date>2/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1990</txnID>
    <date>1/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1991</txnID>
    <date>8/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1992</txnID>
    <date>3/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1993</txnID>
    <date>9/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1994</txnID>
    <date>7/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>1995</txnID>
    <date>5/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>1996</txnID>
    <date>9/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>1997</txnID>
    <date>8/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>1998</txnID>
    <date>10/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>1999</txnID>
    <date>6/7/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2000</txnID>
    <date>6/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2001</txnID>
    <date>4/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2002</txnID>
    <date>9/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2003</txnID>
    <date>9/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2004</txnID>
    <date>9/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2005</txnID>
    <date>4/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2006</txnID>
    <date>1/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2007</txnID>
    <date>4/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2008</txnID>
    <date>8/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2009</txnID>
    <date>9/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2010</txnID>
    <date>10/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2011</txnID>
    <date>6/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2012</txnID>
    <date>10/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2013</txnID>
    <date>10/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2014</txnID>
    <date>6/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2015</txnID>
    <date>3/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2016</txnID>
    <date>10/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2017</txnID>
    <date>11/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2018</txnID>
    <date>9/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2019</txnID>
    <date>5/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2020</txnID>
    <date>2/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2021</txnID>
    <date>8/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2022</txnID>
    <date>10/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2023</txnID>
    <date>9/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2024</txnID>
    <date>9/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2025</txnID>
    <date>8/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2026</txnID>
    <date>6/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2027</txnID>
    <date>3/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2028</txnID>
    <date>7/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2029</txnID>
    <date>4/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2030</txnID>
    <date>11/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2031</txnID>
    <date>5/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2032</txnID>
    <date>6/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2033</txnID>
    <date>9/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2034</txnID>
    <date>3/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2035</txnID>
    <date>8/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2036</txnID>
    <date>5/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2037</txnID>
    <date>9/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2038</txnID>
    <date>3/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2039</txnID>
    <date>3/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2040</txnID>
    <date>5/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2041</txnID>
    <date>12/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2042</txnID>
    <date>8/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2043</txnID>
    <date>9/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2044</txnID>
    <date>8/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2045</txnID>
    <date>9/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2046</txnID>
    <date>11/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2047</txnID>
    <date>12/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2048</txnID>
    <date>8/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2049</txnID>
    <date>11/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2050</txnID>
    <date>7/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2051</txnID>
    <date>4/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2052</txnID>
    <date>6/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2053</txnID>
    <date>2/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2054</txnID>
    <date>4/12/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2055</txnID>
    <date>3/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2056</txnID>
    <date>7/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2057</txnID>
    <date>4/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2058</txnID>
    <date>8/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2059</txnID>
    <date>3/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2060</txnID>
    <date>11/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2061</txnID>
    <date>10/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2062</txnID>
    <date>7/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2063</txnID>
    <date>5/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2064</txnID>
    <date>9/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2065</txnID>
    <date>2/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2066</txnID>
    <date>9/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2067</txnID>
    <date>2/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2068</txnID>
    <date>2/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2069</txnID>
    <date>8/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2070</txnID>
    <date>8/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2071</txnID>
    <date>10/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2072</txnID>
    <date>7/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2073</txnID>
    <date>2/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2074</txnID>
    <date>3/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2075</txnID>
    <date>6/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2076</txnID>
    <date>10/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2077</txnID>
    <date>5/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2078</txnID>
    <date>2/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2079</txnID>
    <date>5/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2080</txnID>
    <date>3/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2081</txnID>
    <date>5/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2082</txnID>
    <date>10/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2083</txnID>
    <date>5/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2084</txnID>
    <date>11/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2085</txnID>
    <date>5/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2086</txnID>
    <date>9/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2087</txnID>
    <date>8/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2088</txnID>
    <date>2/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2089</txnID>
    <date>1/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2090</txnID>
    <date>9/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2091</txnID>
    <date>3/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2092</txnID>
    <date>2/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2093</txnID>
    <date>12/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2094</txnID>
    <date>8/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2095</txnID>
    <date>10/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2096</txnID>
    <date>9/28/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2097</txnID>
    <date>8/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2098</txnID>
    <date>7/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2099</txnID>
    <date>6/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2100</txnID>
    <date>4/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2101</txnID>
    <date>8/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2102</txnID>
    <date>5/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2103</txnID>
    <date>4/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2104</txnID>
    <date>2/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2105</txnID>
    <date>7/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2106</txnID>
    <date>6/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2107</txnID>
    <date>9/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2108</txnID>
    <date>4/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2109</txnID>
    <date>3/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2110</txnID>
    <date>7/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2111</txnID>
    <date>5/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2112</txnID>
    <date>6/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2113</txnID>
    <date>2/28/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2114</txnID>
    <date>5/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2115</txnID>
    <date>9/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2116</txnID>
    <date>10/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2117</txnID>
    <date>3/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2118</txnID>
    <date>7/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2119</txnID>
    <date>5/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2120</txnID>
    <date>8/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2121</txnID>
    <date>4/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2122</txnID>
    <date>4/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2123</txnID>
    <date>4/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2124</txnID>
    <date>10/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2125</txnID>
    <date>11/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2126</txnID>
    <date>9/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2127</txnID>
    <date>9/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2128</txnID>
    <date>4/25/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2129</txnID>
    <date>7/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2130</txnID>
    <date>11/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2131</txnID>
    <date>12/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2132</txnID>
    <date>9/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2133</txnID>
    <date>8/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2134</txnID>
    <date>5/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2135</txnID>
    <date>3/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2136</txnID>
    <date>7/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2137</txnID>
    <date>9/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2138</txnID>
    <date>7/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2139</txnID>
    <date>8/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2140</txnID>
    <date>10/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2141</txnID>
    <date>4/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2142</txnID>
    <date>12/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2143</txnID>
    <date>10/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2144</txnID>
    <date>4/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2145</txnID>
    <date>9/14/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2146</txnID>
    <date>12/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2147</txnID>
    <date>2/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2148</txnID>
    <date>10/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2149</txnID>
    <date>4/1/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2150</txnID>
    <date>3/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2151</txnID>
    <date>7/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2152</txnID>
    <date>3/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2153</txnID>
    <date>9/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2154</txnID>
    <date>6/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2155</txnID>
    <date>1/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2156</txnID>
    <date>10/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2157</txnID>
    <date>8/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2158</txnID>
    <date>11/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2159</txnID>
    <date>4/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2160</txnID>
    <date>2/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2161</txnID>
    <date>2/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2162</txnID>
    <date>8/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2163</txnID>
    <date>6/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2164</txnID>
    <date>5/1/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2165</txnID>
    <date>12/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2166</txnID>
    <date>3/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2167</txnID>
    <date>2/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2168</txnID>
    <date>11/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2169</txnID>
    <date>12/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2170</txnID>
    <date>10/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2171</txnID>
    <date>1/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2172</txnID>
    <date>5/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2173</txnID>
    <date>10/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2174</txnID>
    <date>4/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2175</txnID>
    <date>2/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2176</txnID>
    <date>6/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2177</txnID>
    <date>11/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2178</txnID>
    <date>6/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2179</txnID>
    <date>7/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2180</txnID>
    <date>6/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2181</txnID>
    <date>6/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2182</txnID>
    <date>1/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2183</txnID>
    <date>12/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2184</txnID>
    <date>3/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2185</txnID>
    <date>8/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2186</txnID>
    <date>4/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2187</txnID>
    <date>8/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2188</txnID>
    <date>10/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2189</txnID>
    <date>12/19/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2190</txnID>
    <date>7/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2191</txnID>
    <date>11/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2192</txnID>
    <date>5/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2193</txnID>
    <date>12/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2194</txnID>
    <date>9/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2195</txnID>
    <date>11/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2196</txnID>
    <date>3/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2197</txnID>
    <date>11/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2198</txnID>
    <date>6/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2199</txnID>
    <date>7/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2200</txnID>
    <date>11/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2201</txnID>
    <date>4/7/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2202</txnID>
    <date>7/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2203</txnID>
    <date>5/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2204</txnID>
    <date>8/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2205</txnID>
    <date>9/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2206</txnID>
    <date>4/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2207</txnID>
    <date>10/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2208</txnID>
    <date>4/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2209</txnID>
    <date>8/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2210</txnID>
    <date>5/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2211</txnID>
    <date>11/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2212</txnID>
    <date>3/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2213</txnID>
    <date>11/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2214</txnID>
    <date>2/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2215</txnID>
    <date>10/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2216</txnID>
    <date>6/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2217</txnID>
    <date>7/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2218</txnID>
    <date>12/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2219</txnID>
    <date>7/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2220</txnID>
    <date>3/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2221</txnID>
    <date>6/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2222</txnID>
    <date>8/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2223</txnID>
    <date>11/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2224</txnID>
    <date>9/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2225</txnID>
    <date>10/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2226</txnID>
    <date>3/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2227</txnID>
    <date>4/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2228</txnID>
    <date>5/1/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2229</txnID>
    <date>10/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2230</txnID>
    <date>10/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2231</txnID>
    <date>1/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2232</txnID>
    <date>10/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2233</txnID>
    <date>6/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2234</txnID>
    <date>12/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2235</txnID>
    <date>3/28/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2236</txnID>
    <date>8/25/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2237</txnID>
    <date>4/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2238</txnID>
    <date>1/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2239</txnID>
    <date>12/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2240</txnID>
    <date>3/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2241</txnID>
    <date>4/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2242</txnID>
    <date>12/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2243</txnID>
    <date>6/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2244</txnID>
    <date>12/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2245</txnID>
    <date>11/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2246</txnID>
    <date>3/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2247</txnID>
    <date>9/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2248</txnID>
    <date>10/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2249</txnID>
    <date>6/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2250</txnID>
    <date>6/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2251</txnID>
    <date>10/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2252</txnID>
    <date>2/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2253</txnID>
    <date>5/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2254</txnID>
    <date>4/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2255</txnID>
    <date>11/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2256</txnID>
    <date>10/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2257</txnID>
    <date>10/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2258</txnID>
    <date>3/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2259</txnID>
    <date>1/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2260</txnID>
    <date>8/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2261</txnID>
    <date>10/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2262</txnID>
    <date>12/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2263</txnID>
    <date>6/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2264</txnID>
    <date>7/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2265</txnID>
    <date>6/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2266</txnID>
    <date>2/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2267</txnID>
    <date>10/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2268</txnID>
    <date>2/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2269</txnID>
    <date>5/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2270</txnID>
    <date>10/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2271</txnID>
    <date>10/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2272</txnID>
    <date>11/4/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2273</txnID>
    <date>5/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2274</txnID>
    <date>6/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2275</txnID>
    <date>4/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2276</txnID>
    <date>2/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2277</txnID>
    <date>4/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2278</txnID>
    <date>5/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2279</txnID>
    <date>12/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2280</txnID>
    <date>9/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2281</txnID>
    <date>10/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2282</txnID>
    <date>4/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2283</txnID>
    <date>2/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2284</txnID>
    <date>5/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2285</txnID>
    <date>10/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2286</txnID>
    <date>12/1/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2287</txnID>
    <date>7/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2288</txnID>
    <date>5/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2289</txnID>
    <date>7/3/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2290</txnID>
    <date>12/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2291</txnID>
    <date>12/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2292</txnID>
    <date>6/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2293</txnID>
    <date>8/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2294</txnID>
    <date>2/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2295</txnID>
    <date>7/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2296</txnID>
    <date>5/7/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2297</txnID>
    <date>1/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2298</txnID>
    <date>5/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2299</txnID>
    <date>7/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2300</txnID>
    <date>7/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2301</txnID>
    <date>1/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2302</txnID>
    <date>10/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2303</txnID>
    <date>10/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2304</txnID>
    <date>2/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2305</txnID>
    <date>9/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2306</txnID>
    <date>8/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2307</txnID>
    <date>5/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2308</txnID>
    <date>9/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2309</txnID>
    <date>10/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2310</txnID>
    <date>6/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2311</txnID>
    <date>6/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2312</txnID>
    <date>8/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2313</txnID>
    <date>4/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2314</txnID>
    <date>10/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2315</txnID>
    <date>4/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2316</txnID>
    <date>4/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2317</txnID>
    <date>10/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2318</txnID>
    <date>6/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2319</txnID>
    <date>2/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2320</txnID>
    <date>9/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2321</txnID>
    <date>6/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2322</txnID>
    <date>2/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2323</txnID>
    <date>9/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2324</txnID>
    <date>1/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2325</txnID>
    <date>5/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2326</txnID>
    <date>11/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2327</txnID>
    <date>5/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2328</txnID>
    <date>3/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2329</txnID>
    <date>7/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2330</txnID>
    <date>8/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2331</txnID>
    <date>4/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2332</txnID>
    <date>9/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2333</txnID>
    <date>11/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2334</txnID>
    <date>3/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2335</txnID>
    <date>2/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2336</txnID>
    <date>2/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2337</txnID>
    <date>11/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2338</txnID>
    <date>2/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2339</txnID>
    <date>12/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2340</txnID>
    <date>9/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2341</txnID>
    <date>11/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2342</txnID>
    <date>2/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2343</txnID>
    <date>9/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2344</txnID>
    <date>2/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2345</txnID>
    <date>8/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2346</txnID>
    <date>2/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2347</txnID>
    <date>7/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2348</txnID>
    <date>7/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2349</txnID>
    <date>6/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2350</txnID>
    <date>8/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2351</txnID>
    <date>9/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2352</txnID>
    <date>7/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2353</txnID>
    <date>11/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2354</txnID>
    <date>6/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2355</txnID>
    <date>2/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2356</txnID>
    <date>6/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2357</txnID>
    <date>1/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2358</txnID>
    <date>9/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2359</txnID>
    <date>4/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2360</txnID>
    <date>4/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2361</txnID>
    <date>8/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2362</txnID>
    <date>7/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2363</txnID>
    <date>11/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2364</txnID>
    <date>9/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2365</txnID>
    <date>10/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2366</txnID>
    <date>11/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2367</txnID>
    <date>12/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2368</txnID>
    <date>1/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2369</txnID>
    <date>4/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2370</txnID>
    <date>2/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2371</txnID>
    <date>10/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2372</txnID>
    <date>10/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2373</txnID>
    <date>8/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2374</txnID>
    <date>7/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2375</txnID>
    <date>3/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2376</txnID>
    <date>7/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2377</txnID>
    <date>6/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2378</txnID>
    <date>6/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2379</txnID>
    <date>7/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2380</txnID>
    <date>5/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2381</txnID>
    <date>10/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2382</txnID>
    <date>1/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2383</txnID>
    <date>7/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2384</txnID>
    <date>4/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2385</txnID>
    <date>5/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2386</txnID>
    <date>2/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2387</txnID>
    <date>4/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2388</txnID>
    <date>10/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2389</txnID>
    <date>11/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2390</txnID>
    <date>7/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2391</txnID>
    <date>2/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2392</txnID>
    <date>8/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2393</txnID>
    <date>7/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2394</txnID>
    <date>9/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2395</txnID>
    <date>2/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2396</txnID>
    <date>9/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2397</txnID>
    <date>5/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2398</txnID>
    <date>9/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2399</txnID>
    <date>11/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2400</txnID>
    <date>6/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2401</txnID>
    <date>6/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2402</txnID>
    <date>5/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2403</txnID>
    <date>4/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2404</txnID>
    <date>6/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2405</txnID>
    <date>10/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2406</txnID>
    <date>6/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2407</txnID>
    <date>12/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2408</txnID>
    <date>7/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2409</txnID>
    <date>7/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2410</txnID>
    <date>4/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2411</txnID>
    <date>3/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2412</txnID>
    <date>11/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2413</txnID>
    <date>3/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2414</txnID>
    <date>9/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2415</txnID>
    <date>10/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2416</txnID>
    <date>2/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2417</txnID>
    <date>9/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2418</txnID>
    <date>11/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2419</txnID>
    <date>2/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2420</txnID>
    <date>6/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2421</txnID>
    <date>8/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2422</txnID>
    <date>9/28/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2423</txnID>
    <date>2/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2424</txnID>
    <date>11/21/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2425</txnID>
    <date>10/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2426</txnID>
    <date>6/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2427</txnID>
    <date>7/7/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2428</txnID>
    <date>3/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2429</txnID>
    <date>12/23/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2430</txnID>
    <date>8/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2431</txnID>
    <date>10/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2432</txnID>
    <date>7/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2433</txnID>
    <date>11/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2434</txnID>
    <date>6/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2435</txnID>
    <date>7/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2436</txnID>
    <date>5/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2437</txnID>
    <date>5/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2438</txnID>
    <date>11/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2439</txnID>
    <date>11/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2440</txnID>
    <date>5/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2441</txnID>
    <date>10/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2442</txnID>
    <date>9/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2443</txnID>
    <date>11/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2444</txnID>
    <date>10/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2445</txnID>
    <date>9/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2446</txnID>
    <date>4/23/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2447</txnID>
    <date>5/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2448</txnID>
    <date>2/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2449</txnID>
    <date>9/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>2000</qty>
    <amount>7740</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2450</txnID>
    <date>8/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2451</txnID>
    <date>2/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2452</txnID>
    <date>4/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2453</txnID>
    <date>3/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2454</txnID>
    <date>2/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2455</txnID>
    <date>2/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2456</txnID>
    <date>6/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2457</txnID>
    <date>9/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2458</txnID>
    <date>5/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2459</txnID>
    <date>2/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2460</txnID>
    <date>3/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2461</txnID>
    <date>2/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2462</txnID>
    <date>9/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2463</txnID>
    <date>11/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2464</txnID>
    <date>5/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2465</txnID>
    <date>6/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2466</txnID>
    <date>2/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2467</txnID>
    <date>6/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2468</txnID>
    <date>6/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2469</txnID>
    <date>12/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2470</txnID>
    <date>7/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2471</txnID>
    <date>7/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2472</txnID>
    <date>1/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2473</txnID>
    <date>4/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2474</txnID>
    <date>3/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2475</txnID>
    <date>4/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2476</txnID>
    <date>10/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2477</txnID>
    <date>1/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2478</txnID>
    <date>10/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2479</txnID>
    <date>6/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2480</txnID>
    <date>10/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2481</txnID>
    <date>3/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2482</txnID>
    <date>11/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2483</txnID>
    <date>12/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2484</txnID>
    <date>4/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2485</txnID>
    <date>7/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2486</txnID>
    <date>6/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2487</txnID>
    <date>7/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2488</txnID>
    <date>3/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2489</txnID>
    <date>2/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2490</txnID>
    <date>2/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2491</txnID>
    <date>8/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2492</txnID>
    <date>5/1/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2493</txnID>
    <date>7/1/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2494</txnID>
    <date>12/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2495</txnID>
    <date>9/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2496</txnID>
    <date>7/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2497</txnID>
    <date>2/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2498</txnID>
    <date>11/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2499</txnID>
    <date>11/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2500</txnID>
    <date>9/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2501</txnID>
    <date>7/8/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2502</txnID>
    <date>4/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2503</txnID>
    <date>11/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2504</txnID>
    <date>3/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2505</txnID>
    <date>7/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2506</txnID>
    <date>12/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2507</txnID>
    <date>8/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2508</txnID>
    <date>11/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2509</txnID>
    <date>6/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2510</txnID>
    <date>9/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2511</txnID>
    <date>5/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2512</txnID>
    <date>8/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2513</txnID>
    <date>6/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2514</txnID>
    <date>2/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2515</txnID>
    <date>7/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2516</txnID>
    <date>7/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2517</txnID>
    <date>3/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2518</txnID>
    <date>7/28/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2519</txnID>
    <date>11/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2520</txnID>
    <date>8/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2521</txnID>
    <date>6/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2522</txnID>
    <date>9/27/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2523</txnID>
    <date>2/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2524</txnID>
    <date>2/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2525</txnID>
    <date>3/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2526</txnID>
    <date>10/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2527</txnID>
    <date>12/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2528</txnID>
    <date>8/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2529</txnID>
    <date>11/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2530</txnID>
    <date>11/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2531</txnID>
    <date>7/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2532</txnID>
    <date>11/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2533</txnID>
    <date>3/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2534</txnID>
    <date>7/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2535</txnID>
    <date>6/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2536</txnID>
    <date>7/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2537</txnID>
    <date>5/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2538</txnID>
    <date>11/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2539</txnID>
    <date>12/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2540</txnID>
    <date>12/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2541</txnID>
    <date>8/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2542</txnID>
    <date>6/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2543</txnID>
    <date>5/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2544</txnID>
    <date>2/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2545</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2546</txnID>
    <date>11/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2547</txnID>
    <date>11/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2548</txnID>
    <date>4/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2549</txnID>
    <date>5/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2550</txnID>
    <date>2/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2551</txnID>
    <date>8/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2552</txnID>
    <date>5/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2553</txnID>
    <date>2/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2554</txnID>
    <date>7/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2555</txnID>
    <date>2/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2556</txnID>
    <date>4/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2557</txnID>
    <date>1/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2558</txnID>
    <date>4/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2559</txnID>
    <date>2/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2560</txnID>
    <date>1/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2561</txnID>
    <date>11/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2562</txnID>
    <date>8/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2563</txnID>
    <date>4/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2564</txnID>
    <date>5/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2565</txnID>
    <date>12/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2566</txnID>
    <date>6/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2567</txnID>
    <date>6/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2568</txnID>
    <date>8/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2569</txnID>
    <date>3/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2570</txnID>
    <date>1/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2571</txnID>
    <date>1/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2572</txnID>
    <date>11/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2573</txnID>
    <date>3/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2574</txnID>
    <date>11/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2575</txnID>
    <date>8/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2576</txnID>
    <date>5/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2577</txnID>
    <date>1/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2578</txnID>
    <date>1/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2579</txnID>
    <date>10/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2580</txnID>
    <date>5/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2581</txnID>
    <date>11/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2582</txnID>
    <date>7/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2583</txnID>
    <date>6/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2584</txnID>
    <date>1/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2585</txnID>
    <date>11/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2586</txnID>
    <date>8/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2587</txnID>
    <date>9/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2588</txnID>
    <date>11/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2589</txnID>
    <date>5/7/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2590</txnID>
    <date>11/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2591</txnID>
    <date>2/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2592</txnID>
    <date>4/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2593</txnID>
    <date>7/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2594</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2595</txnID>
    <date>3/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2596</txnID>
    <date>9/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2597</txnID>
    <date>3/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2598</txnID>
    <date>8/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2599</txnID>
    <date>10/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2600</txnID>
    <date>7/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2601</txnID>
    <date>7/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2602</txnID>
    <date>10/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2603</txnID>
    <date>9/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2604</txnID>
    <date>9/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2605</txnID>
    <date>9/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2606</txnID>
    <date>4/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2607</txnID>
    <date>8/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2608</txnID>
    <date>8/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2609</txnID>
    <date>11/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2610</txnID>
    <date>7/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2611</txnID>
    <date>4/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2612</txnID>
    <date>3/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2613</txnID>
    <date>1/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2614</txnID>
    <date>8/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2615</txnID>
    <date>4/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2616</txnID>
    <date>10/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2617</txnID>
    <date>3/1/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2618</txnID>
    <date>3/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2619</txnID>
    <date>5/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2620</txnID>
    <date>1/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2621</txnID>
    <date>10/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2622</txnID>
    <date>4/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2623</txnID>
    <date>7/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2624</txnID>
    <date>10/1/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2625</txnID>
    <date>11/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2626</txnID>
    <date>8/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2627</txnID>
    <date>11/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2628</txnID>
    <date>10/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2629</txnID>
    <date>8/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2630</txnID>
    <date>11/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2631</txnID>
    <date>1/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2632</txnID>
    <date>1/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2633</txnID>
    <date>8/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2634</txnID>
    <date>1/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2635</txnID>
    <date>11/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2636</txnID>
    <date>11/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2637</txnID>
    <date>5/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2638</txnID>
    <date>10/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2639</txnID>
    <date>11/28/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2640</txnID>
    <date>4/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2641</txnID>
    <date>8/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2642</txnID>
    <date>2/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2643</txnID>
    <date>11/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2644</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2645</txnID>
    <date>10/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2646</txnID>
    <date>6/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2647</txnID>
    <date>4/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2648</txnID>
    <date>3/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2649</txnID>
    <date>3/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2650</txnID>
    <date>8/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2651</txnID>
    <date>8/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2652</txnID>
    <date>2/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2653</txnID>
    <date>8/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2654</txnID>
    <date>1/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2655</txnID>
    <date>12/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2656</txnID>
    <date>4/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2657</txnID>
    <date>3/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2658</txnID>
    <date>10/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2659</txnID>
    <date>2/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2660</txnID>
    <date>10/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2661</txnID>
    <date>10/23/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2662</txnID>
    <date>12/17/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2663</txnID>
    <date>7/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2664</txnID>
    <date>3/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2665</txnID>
    <date>2/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2666</txnID>
    <date>5/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2667</txnID>
    <date>12/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2668</txnID>
    <date>11/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2669</txnID>
    <date>4/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2670</txnID>
    <date>5/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2671</txnID>
    <date>9/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2672</txnID>
    <date>5/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2673</txnID>
    <date>9/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2674</txnID>
    <date>12/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2675</txnID>
    <date>5/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2676</txnID>
    <date>8/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2677</txnID>
    <date>1/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2678</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2679</txnID>
    <date>5/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2680</txnID>
    <date>4/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2681</txnID>
    <date>4/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2682</txnID>
    <date>2/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2683</txnID>
    <date>10/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2684</txnID>
    <date>10/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2685</txnID>
    <date>10/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2686</txnID>
    <date>5/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2687</txnID>
    <date>11/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2688</txnID>
    <date>6/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2689</txnID>
    <date>11/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2690</txnID>
    <date>5/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2691</txnID>
    <date>7/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2692</txnID>
    <date>2/10/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2693</txnID>
    <date>8/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2694</txnID>
    <date>8/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2695</txnID>
    <date>4/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2696</txnID>
    <date>3/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2697</txnID>
    <date>5/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2698</txnID>
    <date>3/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2699</txnID>
    <date>11/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2700</txnID>
    <date>9/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2701</txnID>
    <date>4/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2702</txnID>
    <date>1/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2703</txnID>
    <date>11/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2704</txnID>
    <date>8/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2705</txnID>
    <date>1/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2706</txnID>
    <date>1/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2707</txnID>
    <date>3/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2708</txnID>
    <date>6/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2709</txnID>
    <date>2/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2710</txnID>
    <date>5/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2711</txnID>
    <date>10/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2712</txnID>
    <date>1/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2713</txnID>
    <date>2/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2714</txnID>
    <date>4/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2715</txnID>
    <date>10/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2716</txnID>
    <date>11/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2717</txnID>
    <date>8/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2718</txnID>
    <date>7/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2719</txnID>
    <date>6/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2720</txnID>
    <date>12/15/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2721</txnID>
    <date>4/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2722</txnID>
    <date>11/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2723</txnID>
    <date>8/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2724</txnID>
    <date>12/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2725</txnID>
    <date>7/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2726</txnID>
    <date>8/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2727</txnID>
    <date>4/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2728</txnID>
    <date>10/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2729</txnID>
    <date>2/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2730</txnID>
    <date>10/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2731</txnID>
    <date>3/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2732</txnID>
    <date>6/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2733</txnID>
    <date>10/5/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2734</txnID>
    <date>7/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2735</txnID>
    <date>10/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2736</txnID>
    <date>2/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2737</txnID>
    <date>6/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2738</txnID>
    <date>4/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2739</txnID>
    <date>3/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2740</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2741</txnID>
    <date>7/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2742</txnID>
    <date>5/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2743</txnID>
    <date>6/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2744</txnID>
    <date>10/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2745</txnID>
    <date>7/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2746</txnID>
    <date>9/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2747</txnID>
    <date>7/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2748</txnID>
    <date>9/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2749</txnID>
    <date>8/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2750</txnID>
    <date>9/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2751</txnID>
    <date>11/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2752</txnID>
    <date>2/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2753</txnID>
    <date>9/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2754</txnID>
    <date>1/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2755</txnID>
    <date>11/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2756</txnID>
    <date>10/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2757</txnID>
    <date>8/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2758</txnID>
    <date>7/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2759</txnID>
    <date>3/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2760</txnID>
    <date>2/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2761</txnID>
    <date>4/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2762</txnID>
    <date>10/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2763</txnID>
    <date>10/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2764</txnID>
    <date>12/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2765</txnID>
    <date>10/13/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2766</txnID>
    <date>10/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2767</txnID>
    <date>6/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2768</txnID>
    <date>12/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2769</txnID>
    <date>5/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2770</txnID>
    <date>2/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2771</txnID>
    <date>7/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2772</txnID>
    <date>7/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2773</txnID>
    <date>11/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2774</txnID>
    <date>9/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2775</txnID>
    <date>6/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2776</txnID>
    <date>6/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2777</txnID>
    <date>1/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2778</txnID>
    <date>10/20/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2779</txnID>
    <date>8/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2780</txnID>
    <date>6/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2781</txnID>
    <date>12/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2782</txnID>
    <date>9/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2783</txnID>
    <date>4/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2784</txnID>
    <date>2/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2785</txnID>
    <date>1/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2786</txnID>
    <date>10/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2787</txnID>
    <date>3/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2788</txnID>
    <date>4/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2789</txnID>
    <date>2/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2790</txnID>
    <date>9/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2791</txnID>
    <date>11/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2792</txnID>
    <date>10/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2793</txnID>
    <date>7/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2794</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2795</txnID>
    <date>4/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2796</txnID>
    <date>8/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2797</txnID>
    <date>8/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2798</txnID>
    <date>4/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2799</txnID>
    <date>11/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2800</txnID>
    <date>8/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2801</txnID>
    <date>6/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2802</txnID>
    <date>12/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2803</txnID>
    <date>9/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2804</txnID>
    <date>10/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2805</txnID>
    <date>3/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2806</txnID>
    <date>9/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2807</txnID>
    <date>7/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2808</txnID>
    <date>8/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2809</txnID>
    <date>5/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2810</txnID>
    <date>5/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2811</txnID>
    <date>8/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2812</txnID>
    <date>7/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2813</txnID>
    <date>3/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2814</txnID>
    <date>11/7/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2815</txnID>
    <date>6/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2816</txnID>
    <date>10/22/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2817</txnID>
    <date>4/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2818</txnID>
    <date>5/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2819</txnID>
    <date>12/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2820</txnID>
    <date>7/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2821</txnID>
    <date>2/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2822</txnID>
    <date>7/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2823</txnID>
    <date>11/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2824</txnID>
    <date>4/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2825</txnID>
    <date>7/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2826</txnID>
    <date>11/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2827</txnID>
    <date>1/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2828</txnID>
    <date>5/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2829</txnID>
    <date>9/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2830</txnID>
    <date>5/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2831</txnID>
    <date>12/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2832</txnID>
    <date>3/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2833</txnID>
    <date>3/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2834</txnID>
    <date>4/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2835</txnID>
    <date>2/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2836</txnID>
    <date>7/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2837</txnID>
    <date>5/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2838</txnID>
    <date>5/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2839</txnID>
    <date>11/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2840</txnID>
    <date>3/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2841</txnID>
    <date>7/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2842</txnID>
    <date>6/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2843</txnID>
    <date>8/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2844</txnID>
    <date>11/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2845</txnID>
    <date>7/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2846</txnID>
    <date>6/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2847</txnID>
    <date>4/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2848</txnID>
    <date>12/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2849</txnID>
    <date>9/18/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2850</txnID>
    <date>2/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2851</txnID>
    <date>11/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2852</txnID>
    <date>10/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2853</txnID>
    <date>2/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2854</txnID>
    <date>7/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2855</txnID>
    <date>11/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2856</txnID>
    <date>10/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2857</txnID>
    <date>5/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2858</txnID>
    <date>4/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2859</txnID>
    <date>5/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2860</txnID>
    <date>9/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2861</txnID>
    <date>5/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2862</txnID>
    <date>10/2/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2863</txnID>
    <date>3/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2864</txnID>
    <date>3/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2865</txnID>
    <date>1/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2866</txnID>
    <date>3/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2867</txnID>
    <date>12/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2868</txnID>
    <date>12/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2869</txnID>
    <date>7/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2870</txnID>
    <date>8/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2871</txnID>
    <date>8/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2872</txnID>
    <date>6/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2873</txnID>
    <date>7/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2874</txnID>
    <date>3/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2875</txnID>
    <date>4/8/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2876</txnID>
    <date>7/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2877</txnID>
    <date>3/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2878</txnID>
    <date>2/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2879</txnID>
    <date>6/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2880</txnID>
    <date>1/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2881</txnID>
    <date>4/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2882</txnID>
    <date>9/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2883</txnID>
    <date>9/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2884</txnID>
    <date>10/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2885</txnID>
    <date>7/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2886</txnID>
    <date>11/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2887</txnID>
    <date>9/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2888</txnID>
    <date>3/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2889</txnID>
    <date>2/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2890</txnID>
    <date>5/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2891</txnID>
    <date>7/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2892</txnID>
    <date>10/1/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2893</txnID>
    <date>7/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2894</txnID>
    <date>10/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2895</txnID>
    <date>4/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2896</txnID>
    <date>10/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2897</txnID>
    <date>10/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2898</txnID>
    <date>6/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2899</txnID>
    <date>5/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2900</txnID>
    <date>3/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2901</txnID>
    <date>7/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2902</txnID>
    <date>6/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2903</txnID>
    <date>7/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2904</txnID>
    <date>4/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2905</txnID>
    <date>10/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2906</txnID>
    <date>7/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2907</txnID>
    <date>10/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2908</txnID>
    <date>10/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2909</txnID>
    <date>12/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2910</txnID>
    <date>11/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2911</txnID>
    <date>10/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2912</txnID>
    <date>3/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2913</txnID>
    <date>3/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2914</txnID>
    <date>3/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2915</txnID>
    <date>10/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2916</txnID>
    <date>4/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2917</txnID>
    <date>11/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2918</txnID>
    <date>8/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2919</txnID>
    <date>2/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2920</txnID>
    <date>2/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2921</txnID>
    <date>9/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2922</txnID>
    <date>8/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2923</txnID>
    <date>3/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2924</txnID>
    <date>5/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2925</txnID>
    <date>1/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2926</txnID>
    <date>5/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2927</txnID>
    <date>9/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2928</txnID>
    <date>4/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2929</txnID>
    <date>6/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2930</txnID>
    <date>3/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2931</txnID>
    <date>9/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2932</txnID>
    <date>9/28/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2933</txnID>
    <date>9/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2934</txnID>
    <date>2/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2935</txnID>
    <date>8/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2936</txnID>
    <date>11/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2937</txnID>
    <date>8/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2938</txnID>
    <date>7/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2939</txnID>
    <date>7/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2940</txnID>
    <date>2/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2941</txnID>
    <date>9/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2942</txnID>
    <date>5/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2943</txnID>
    <date>12/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2944</txnID>
    <date>11/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2945</txnID>
    <date>5/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2946</txnID>
    <date>11/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2947</txnID>
    <date>4/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2948</txnID>
    <date>11/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2949</txnID>
    <date>4/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2950</txnID>
    <date>7/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2951</txnID>
    <date>1/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2952</txnID>
    <date>2/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2953</txnID>
    <date>8/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2954</txnID>
    <date>1/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2955</txnID>
    <date>2/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2956</txnID>
    <date>7/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2957</txnID>
    <date>8/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2958</txnID>
    <date>9/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2959</txnID>
    <date>8/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2960</txnID>
    <date>8/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2961</txnID>
    <date>7/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2962</txnID>
    <date>1/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2963</txnID>
    <date>6/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2964</txnID>
    <date>9/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2965</txnID>
    <date>6/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2966</txnID>
    <date>4/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2967</txnID>
    <date>4/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2968</txnID>
    <date>7/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2969</txnID>
    <date>4/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2970</txnID>
    <date>7/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2971</txnID>
    <date>8/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2972</txnID>
    <date>2/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2973</txnID>
    <date>9/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2974</txnID>
    <date>10/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2975</txnID>
    <date>6/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2976</txnID>
    <date>7/8/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>2977</txnID>
    <date>3/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2978</txnID>
    <date>11/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2979</txnID>
    <date>1/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2980</txnID>
    <date>8/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2981</txnID>
    <date>12/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2982</txnID>
    <date>8/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2983</txnID>
    <date>1/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2984</txnID>
    <date>5/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2985</txnID>
    <date>4/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2986</txnID>
    <date>10/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2987</txnID>
    <date>7/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>2988</txnID>
    <date>7/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2989</txnID>
    <date>6/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2990</txnID>
    <date>5/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2991</txnID>
    <date>7/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2992</txnID>
    <date>6/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2993</txnID>
    <date>8/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2994</txnID>
    <date>2/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2995</txnID>
    <date>2/28/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>2996</txnID>
    <date>11/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>2997</txnID>
    <date>6/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>2998</txnID>
    <date>4/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>2999</txnID>
    <date>9/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3000</txnID>
    <date>2/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3001</txnID>
    <date>1/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3002</txnID>
    <date>4/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3003</txnID>
    <date>6/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3004</txnID>
    <date>2/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3005</txnID>
    <date>4/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3006</txnID>
    <date>10/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3007</txnID>
    <date>3/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3008</txnID>
    <date>11/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3009</txnID>
    <date>5/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3010</txnID>
    <date>11/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3011</txnID>
    <date>7/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3012</txnID>
    <date>2/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3013</txnID>
    <date>4/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3014</txnID>
    <date>6/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3015</txnID>
    <date>10/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3016</txnID>
    <date>8/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3017</txnID>
    <date>8/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3018</txnID>
    <date>4/7/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3019</txnID>
    <date>5/7/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3020</txnID>
    <date>9/4/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3021</txnID>
    <date>6/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3022</txnID>
    <date>8/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3023</txnID>
    <date>5/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3024</txnID>
    <date>3/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3025</txnID>
    <date>1/6/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3026</txnID>
    <date>2/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3027</txnID>
    <date>10/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3028</txnID>
    <date>7/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3029</txnID>
    <date>2/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3030</txnID>
    <date>8/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3031</txnID>
    <date>6/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3032</txnID>
    <date>8/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3033</txnID>
    <date>9/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3034</txnID>
    <date>10/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3035</txnID>
    <date>2/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3036</txnID>
    <date>9/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3037</txnID>
    <date>8/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3038</txnID>
    <date>11/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3039</txnID>
    <date>8/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3040</txnID>
    <date>1/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3041</txnID>
    <date>8/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3042</txnID>
    <date>3/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3043</txnID>
    <date>7/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3044</txnID>
    <date>10/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3045</txnID>
    <date>2/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3046</txnID>
    <date>2/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3047</txnID>
    <date>4/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3048</txnID>
    <date>7/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3049</txnID>
    <date>1/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3050</txnID>
    <date>6/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3051</txnID>
    <date>6/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3052</txnID>
    <date>7/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3053</txnID>
    <date>7/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3054</txnID>
    <date>7/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3055</txnID>
    <date>10/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3056</txnID>
    <date>11/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3057</txnID>
    <date>11/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3058</txnID>
    <date>10/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3059</txnID>
    <date>10/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3060</txnID>
    <date>7/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3061</txnID>
    <date>4/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3062</txnID>
    <date>5/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3063</txnID>
    <date>8/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3064</txnID>
    <date>1/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3065</txnID>
    <date>2/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3066</txnID>
    <date>2/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3067</txnID>
    <date>7/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3068</txnID>
    <date>4/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3069</txnID>
    <date>6/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3070</txnID>
    <date>11/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3071</txnID>
    <date>8/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3072</txnID>
    <date>9/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3073</txnID>
    <date>8/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3074</txnID>
    <date>4/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3075</txnID>
    <date>7/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3076</txnID>
    <date>8/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3077</txnID>
    <date>5/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3078</txnID>
    <date>9/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3079</txnID>
    <date>1/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3080</txnID>
    <date>8/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3081</txnID>
    <date>12/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3082</txnID>
    <date>3/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3083</txnID>
    <date>6/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3084</txnID>
    <date>1/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3085</txnID>
    <date>6/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3086</txnID>
    <date>5/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3087</txnID>
    <date>9/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3088</txnID>
    <date>3/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3089</txnID>
    <date>5/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3090</txnID>
    <date>5/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3091</txnID>
    <date>11/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3092</txnID>
    <date>12/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3093</txnID>
    <date>6/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3094</txnID>
    <date>9/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3095</txnID>
    <date>5/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3096</txnID>
    <date>10/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3097</txnID>
    <date>3/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3098</txnID>
    <date>7/28/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3099</txnID>
    <date>11/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3100</txnID>
    <date>4/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3101</txnID>
    <date>4/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3102</txnID>
    <date>7/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3103</txnID>
    <date>7/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3104</txnID>
    <date>11/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3105</txnID>
    <date>3/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3106</txnID>
    <date>8/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3107</txnID>
    <date>12/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3108</txnID>
    <date>5/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3109</txnID>
    <date>5/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3110</txnID>
    <date>9/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3111</txnID>
    <date>9/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3112</txnID>
    <date>5/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3113</txnID>
    <date>6/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3114</txnID>
    <date>4/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3115</txnID>
    <date>1/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3116</txnID>
    <date>9/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3117</txnID>
    <date>7/14/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3118</txnID>
    <date>3/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3119</txnID>
    <date>11/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3120</txnID>
    <date>3/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3121</txnID>
    <date>5/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3122</txnID>
    <date>4/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3123</txnID>
    <date>3/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3124</txnID>
    <date>7/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3125</txnID>
    <date>10/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3126</txnID>
    <date>7/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3127</txnID>
    <date>4/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3128</txnID>
    <date>5/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3129</txnID>
    <date>12/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3130</txnID>
    <date>7/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3131</txnID>
    <date>12/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3132</txnID>
    <date>6/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3133</txnID>
    <date>7/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3134</txnID>
    <date>1/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3135</txnID>
    <date>7/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3136</txnID>
    <date>10/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3137</txnID>
    <date>5/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3138</txnID>
    <date>4/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3139</txnID>
    <date>10/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3140</txnID>
    <date>4/14/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3141</txnID>
    <date>3/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3142</txnID>
    <date>6/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3143</txnID>
    <date>4/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3144</txnID>
    <date>5/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3145</txnID>
    <date>9/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3146</txnID>
    <date>12/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3147</txnID>
    <date>7/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3148</txnID>
    <date>6/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3149</txnID>
    <date>3/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3150</txnID>
    <date>10/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3151</txnID>
    <date>10/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3152</txnID>
    <date>12/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3153</txnID>
    <date>3/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3154</txnID>
    <date>7/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3155</txnID>
    <date>6/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3156</txnID>
    <date>12/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3157</txnID>
    <date>8/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3158</txnID>
    <date>11/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3159</txnID>
    <date>6/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3160</txnID>
    <date>12/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3161</txnID>
    <date>6/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3162</txnID>
    <date>4/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3163</txnID>
    <date>2/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3164</txnID>
    <date>3/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3165</txnID>
    <date>4/16/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3166</txnID>
    <date>5/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3167</txnID>
    <date>2/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3168</txnID>
    <date>1/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3169</txnID>
    <date>5/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3170</txnID>
    <date>8/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3171</txnID>
    <date>2/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3172</txnID>
    <date>8/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3173</txnID>
    <date>7/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3174</txnID>
    <date>8/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3175</txnID>
    <date>5/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3176</txnID>
    <date>8/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3177</txnID>
    <date>9/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3178</txnID>
    <date>6/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3179</txnID>
    <date>3/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3180</txnID>
    <date>8/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3181</txnID>
    <date>7/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3182</txnID>
    <date>10/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3183</txnID>
    <date>7/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3184</txnID>
    <date>11/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3185</txnID>
    <date>5/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3186</txnID>
    <date>10/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3187</txnID>
    <date>7/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3188</txnID>
    <date>2/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3189</txnID>
    <date>12/14/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3190</txnID>
    <date>4/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3191</txnID>
    <date>10/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3192</txnID>
    <date>10/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3193</txnID>
    <date>4/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3194</txnID>
    <date>10/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3195</txnID>
    <date>4/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3196</txnID>
    <date>6/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3197</txnID>
    <date>10/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3198</txnID>
    <date>8/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3199</txnID>
    <date>11/10/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3200</txnID>
    <date>7/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3201</txnID>
    <date>11/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3202</txnID>
    <date>9/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3203</txnID>
    <date>5/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3204</txnID>
    <date>8/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3205</txnID>
    <date>6/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3206</txnID>
    <date>8/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3207</txnID>
    <date>6/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3208</txnID>
    <date>6/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3209</txnID>
    <date>10/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3210</txnID>
    <date>4/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3211</txnID>
    <date>5/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3212</txnID>
    <date>7/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3213</txnID>
    <date>7/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3214</txnID>
    <date>4/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3215</txnID>
    <date>5/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3216</txnID>
    <date>8/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3217</txnID>
    <date>5/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3218</txnID>
    <date>4/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3219</txnID>
    <date>8/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3220</txnID>
    <date>3/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3221</txnID>
    <date>8/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3222</txnID>
    <date>12/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3223</txnID>
    <date>6/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3224</txnID>
    <date>10/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3225</txnID>
    <date>8/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3226</txnID>
    <date>7/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3227</txnID>
    <date>5/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3228</txnID>
    <date>2/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3229</txnID>
    <date>3/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3230</txnID>
    <date>6/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3231</txnID>
    <date>5/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3232</txnID>
    <date>2/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3233</txnID>
    <date>11/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3234</txnID>
    <date>5/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3235</txnID>
    <date>3/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3236</txnID>
    <date>8/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3237</txnID>
    <date>5/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3238</txnID>
    <date>7/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3239</txnID>
    <date>6/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3240</txnID>
    <date>5/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3241</txnID>
    <date>3/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3242</txnID>
    <date>11/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3243</txnID>
    <date>9/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3244</txnID>
    <date>10/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3245</txnID>
    <date>8/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3246</txnID>
    <date>3/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3247</txnID>
    <date>10/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3248</txnID>
    <date>1/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3249</txnID>
    <date>2/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3250</txnID>
    <date>2/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3251</txnID>
    <date>5/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3252</txnID>
    <date>12/27/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3253</txnID>
    <date>9/15/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3254</txnID>
    <date>4/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3255</txnID>
    <date>6/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3256</txnID>
    <date>6/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3257</txnID>
    <date>11/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3258</txnID>
    <date>9/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3259</txnID>
    <date>1/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3260</txnID>
    <date>3/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3261</txnID>
    <date>2/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3262</txnID>
    <date>5/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3263</txnID>
    <date>4/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3264</txnID>
    <date>12/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3265</txnID>
    <date>3/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3266</txnID>
    <date>10/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3267</txnID>
    <date>12/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3268</txnID>
    <date>10/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3269</txnID>
    <date>4/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3270</txnID>
    <date>5/2/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3271</txnID>
    <date>10/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3272</txnID>
    <date>11/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3273</txnID>
    <date>7/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3274</txnID>
    <date>9/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3275</txnID>
    <date>7/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3276</txnID>
    <date>2/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3277</txnID>
    <date>3/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3278</txnID>
    <date>4/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3279</txnID>
    <date>2/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3280</txnID>
    <date>7/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3281</txnID>
    <date>6/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3282</txnID>
    <date>1/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3283</txnID>
    <date>3/1/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3284</txnID>
    <date>10/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3285</txnID>
    <date>11/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3286</txnID>
    <date>2/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3287</txnID>
    <date>7/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3288</txnID>
    <date>11/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3289</txnID>
    <date>11/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3290</txnID>
    <date>2/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3291</txnID>
    <date>11/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3292</txnID>
    <date>6/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3293</txnID>
    <date>5/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3294</txnID>
    <date>3/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3295</txnID>
    <date>6/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3296</txnID>
    <date>4/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3297</txnID>
    <date>11/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3298</txnID>
    <date>5/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3299</txnID>
    <date>3/27/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3300</txnID>
    <date>6/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3301</txnID>
    <date>11/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3302</txnID>
    <date>8/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3303</txnID>
    <date>12/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3304</txnID>
    <date>4/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3305</txnID>
    <date>6/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3306</txnID>
    <date>9/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3307</txnID>
    <date>5/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3308</txnID>
    <date>3/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3309</txnID>
    <date>9/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3310</txnID>
    <date>7/1/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3311</txnID>
    <date>3/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3312</txnID>
    <date>4/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3313</txnID>
    <date>2/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3314</txnID>
    <date>11/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3315</txnID>
    <date>8/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3316</txnID>
    <date>5/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3317</txnID>
    <date>6/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3318</txnID>
    <date>11/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3319</txnID>
    <date>12/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3320</txnID>
    <date>10/8/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3321</txnID>
    <date>6/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3322</txnID>
    <date>4/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3323</txnID>
    <date>3/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3324</txnID>
    <date>7/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3325</txnID>
    <date>3/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3326</txnID>
    <date>11/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3327</txnID>
    <date>9/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3328</txnID>
    <date>3/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3329</txnID>
    <date>7/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3330</txnID>
    <date>11/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3331</txnID>
    <date>2/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3332</txnID>
    <date>9/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3333</txnID>
    <date>12/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3334</txnID>
    <date>4/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3335</txnID>
    <date>8/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3336</txnID>
    <date>3/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3337</txnID>
    <date>6/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3338</txnID>
    <date>5/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3339</txnID>
    <date>5/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3340</txnID>
    <date>8/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3341</txnID>
    <date>6/12/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3342</txnID>
    <date>3/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3343</txnID>
    <date>10/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3344</txnID>
    <date>3/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3345</txnID>
    <date>8/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3346</txnID>
    <date>5/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3347</txnID>
    <date>4/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3348</txnID>
    <date>7/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3349</txnID>
    <date>2/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>100</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3350</txnID>
    <date>2/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3351</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3352</txnID>
    <date>9/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3353</txnID>
    <date>3/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3354</txnID>
    <date>3/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3355</txnID>
    <date>4/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3356</txnID>
    <date>7/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3357</txnID>
    <date>7/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3358</txnID>
    <date>6/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3359</txnID>
    <date>6/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3360</txnID>
    <date>11/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3361</txnID>
    <date>6/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3362</txnID>
    <date>8/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3363</txnID>
    <date>1/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3364</txnID>
    <date>10/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3365</txnID>
    <date>2/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3366</txnID>
    <date>5/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3367</txnID>
    <date>1/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3368</txnID>
    <date>7/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3369</txnID>
    <date>10/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3370</txnID>
    <date>4/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3371</txnID>
    <date>7/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3372</txnID>
    <date>6/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3373</txnID>
    <date>11/24/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3374</txnID>
    <date>5/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3375</txnID>
    <date>9/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3376</txnID>
    <date>6/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3377</txnID>
    <date>8/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3378</txnID>
    <date>6/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3379</txnID>
    <date>5/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3380</txnID>
    <date>7/7/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3381</txnID>
    <date>3/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3382</txnID>
    <date>5/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3383</txnID>
    <date>11/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3384</txnID>
    <date>4/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3385</txnID>
    <date>1/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3386</txnID>
    <date>10/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3387</txnID>
    <date>2/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3388</txnID>
    <date>6/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3389</txnID>
    <date>4/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3390</txnID>
    <date>8/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3391</txnID>
    <date>6/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3392</txnID>
    <date>6/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3393</txnID>
    <date>2/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3394</txnID>
    <date>4/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3395</txnID>
    <date>10/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3396</txnID>
    <date>6/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3397</txnID>
    <date>3/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3398</txnID>
    <date>3/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3399</txnID>
    <date>8/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3400</txnID>
    <date>6/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3401</txnID>
    <date>9/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3402</txnID>
    <date>10/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3403</txnID>
    <date>4/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3404</txnID>
    <date>12/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3405</txnID>
    <date>10/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3406</txnID>
    <date>9/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3407</txnID>
    <date>7/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3408</txnID>
    <date>12/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3409</txnID>
    <date>7/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3410</txnID>
    <date>3/16/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3411</txnID>
    <date>7/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3412</txnID>
    <date>6/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3413</txnID>
    <date>7/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3414</txnID>
    <date>7/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3415</txnID>
    <date>2/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3416</txnID>
    <date>7/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3417</txnID>
    <date>11/1/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3418</txnID>
    <date>5/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3419</txnID>
    <date>3/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3420</txnID>
    <date>7/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3421</txnID>
    <date>5/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3422</txnID>
    <date>6/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3423</txnID>
    <date>8/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3424</txnID>
    <date>7/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3425</txnID>
    <date>11/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3426</txnID>
    <date>9/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3427</txnID>
    <date>8/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3428</txnID>
    <date>4/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3429</txnID>
    <date>6/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3430</txnID>
    <date>5/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3431</txnID>
    <date>5/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3432</txnID>
    <date>10/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3433</txnID>
    <date>11/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3434</txnID>
    <date>5/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3435</txnID>
    <date>3/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3436</txnID>
    <date>10/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3437</txnID>
    <date>10/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3438</txnID>
    <date>7/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3439</txnID>
    <date>1/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3440</txnID>
    <date>4/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3441</txnID>
    <date>9/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3442</txnID>
    <date>8/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3443</txnID>
    <date>10/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3444</txnID>
    <date>9/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3445</txnID>
    <date>11/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3446</txnID>
    <date>4/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3447</txnID>
    <date>4/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3448</txnID>
    <date>10/10/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3449</txnID>
    <date>5/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3450</txnID>
    <date>9/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3451</txnID>
    <date>10/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3452</txnID>
    <date>12/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3453</txnID>
    <date>7/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3454</txnID>
    <date>7/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3455</txnID>
    <date>3/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3456</txnID>
    <date>10/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3457</txnID>
    <date>10/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3458</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3459</txnID>
    <date>6/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3460</txnID>
    <date>5/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3461</txnID>
    <date>10/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3462</txnID>
    <date>1/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3463</txnID>
    <date>2/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3464</txnID>
    <date>6/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3465</txnID>
    <date>6/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3466</txnID>
    <date>3/14/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3467</txnID>
    <date>7/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3468</txnID>
    <date>10/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3469</txnID>
    <date>7/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3470</txnID>
    <date>11/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3471</txnID>
    <date>2/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3472</txnID>
    <date>8/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3473</txnID>
    <date>7/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3474</txnID>
    <date>10/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3475</txnID>
    <date>7/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3476</txnID>
    <date>9/1/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3477</txnID>
    <date>6/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3478</txnID>
    <date>2/22/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3479</txnID>
    <date>2/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3480</txnID>
    <date>8/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3481</txnID>
    <date>5/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3482</txnID>
    <date>6/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3483</txnID>
    <date>9/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3484</txnID>
    <date>7/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3485</txnID>
    <date>12/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3486</txnID>
    <date>9/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3487</txnID>
    <date>6/14/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3488</txnID>
    <date>11/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3489</txnID>
    <date>9/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3490</txnID>
    <date>10/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3491</txnID>
    <date>11/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3492</txnID>
    <date>4/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3493</txnID>
    <date>9/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3494</txnID>
    <date>3/1/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3495</txnID>
    <date>8/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3496</txnID>
    <date>4/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3497</txnID>
    <date>3/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3498</txnID>
    <date>8/26/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3499</txnID>
    <date>8/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3500</txnID>
    <date>5/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3501</txnID>
    <date>6/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3502</txnID>
    <date>12/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3503</txnID>
    <date>10/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3504</txnID>
    <date>7/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3505</txnID>
    <date>7/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3506</txnID>
    <date>8/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3507</txnID>
    <date>11/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3508</txnID>
    <date>2/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3509</txnID>
    <date>9/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3510</txnID>
    <date>3/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3511</txnID>
    <date>11/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3512</txnID>
    <date>12/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3513</txnID>
    <date>8/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3514</txnID>
    <date>5/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3515</txnID>
    <date>9/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3516</txnID>
    <date>12/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3517</txnID>
    <date>6/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3518</txnID>
    <date>10/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3519</txnID>
    <date>10/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3520</txnID>
    <date>11/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3521</txnID>
    <date>2/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3522</txnID>
    <date>9/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3523</txnID>
    <date>6/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3524</txnID>
    <date>2/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3525</txnID>
    <date>1/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3526</txnID>
    <date>6/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3527</txnID>
    <date>11/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3528</txnID>
    <date>2/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3529</txnID>
    <date>11/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3530</txnID>
    <date>7/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3531</txnID>
    <date>3/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3532</txnID>
    <date>5/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3533</txnID>
    <date>11/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3534</txnID>
    <date>10/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3535</txnID>
    <date>4/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3536</txnID>
    <date>11/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3537</txnID>
    <date>5/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3538</txnID>
    <date>5/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3539</txnID>
    <date>9/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3540</txnID>
    <date>4/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3541</txnID>
    <date>9/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3542</txnID>
    <date>4/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3543</txnID>
    <date>4/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3544</txnID>
    <date>6/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3545</txnID>
    <date>2/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3546</txnID>
    <date>2/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3547</txnID>
    <date>10/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3548</txnID>
    <date>1/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3549</txnID>
    <date>6/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3550</txnID>
    <date>3/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3551</txnID>
    <date>6/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3552</txnID>
    <date>8/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3553</txnID>
    <date>1/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3554</txnID>
    <date>1/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3555</txnID>
    <date>12/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3556</txnID>
    <date>3/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3557</txnID>
    <date>4/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3558</txnID>
    <date>9/22/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3559</txnID>
    <date>6/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3560</txnID>
    <date>4/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3561</txnID>
    <date>6/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3562</txnID>
    <date>9/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3563</txnID>
    <date>3/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3564</txnID>
    <date>11/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3565</txnID>
    <date>6/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3566</txnID>
    <date>9/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3567</txnID>
    <date>10/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3568</txnID>
    <date>5/27/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3569</txnID>
    <date>2/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3570</txnID>
    <date>6/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3571</txnID>
    <date>2/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3572</txnID>
    <date>9/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3573</txnID>
    <date>4/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3574</txnID>
    <date>6/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3575</txnID>
    <date>5/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3576</txnID>
    <date>6/2/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3577</txnID>
    <date>10/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3578</txnID>
    <date>5/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3579</txnID>
    <date>2/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3580</txnID>
    <date>7/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3581</txnID>
    <date>1/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3582</txnID>
    <date>10/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3583</txnID>
    <date>7/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3584</txnID>
    <date>9/16/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3585</txnID>
    <date>9/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3586</txnID>
    <date>3/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3587</txnID>
    <date>9/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3588</txnID>
    <date>4/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3589</txnID>
    <date>2/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3590</txnID>
    <date>6/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3591</txnID>
    <date>8/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3592</txnID>
    <date>10/12/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3593</txnID>
    <date>5/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3594</txnID>
    <date>8/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3595</txnID>
    <date>3/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3596</txnID>
    <date>6/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3597</txnID>
    <date>4/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3598</txnID>
    <date>2/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3599</txnID>
    <date>9/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3600</txnID>
    <date>4/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3601</txnID>
    <date>5/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3602</txnID>
    <date>5/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3603</txnID>
    <date>1/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3604</txnID>
    <date>3/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3605</txnID>
    <date>11/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3606</txnID>
    <date>7/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3607</txnID>
    <date>5/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3608</txnID>
    <date>3/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3609</txnID>
    <date>8/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3610</txnID>
    <date>10/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3611</txnID>
    <date>2/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3612</txnID>
    <date>9/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3613</txnID>
    <date>7/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3614</txnID>
    <date>12/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3615</txnID>
    <date>10/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3616</txnID>
    <date>9/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3617</txnID>
    <date>9/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3618</txnID>
    <date>5/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3619</txnID>
    <date>5/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3620</txnID>
    <date>3/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3621</txnID>
    <date>10/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3622</txnID>
    <date>4/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3623</txnID>
    <date>5/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3624</txnID>
    <date>3/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3625</txnID>
    <date>9/19/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3626</txnID>
    <date>12/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3627</txnID>
    <date>7/1/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3628</txnID>
    <date>4/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3629</txnID>
    <date>8/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3630</txnID>
    <date>9/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3631</txnID>
    <date>1/28/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3632</txnID>
    <date>1/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3633</txnID>
    <date>2/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3634</txnID>
    <date>3/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3635</txnID>
    <date>8/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3636</txnID>
    <date>1/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3637</txnID>
    <date>8/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3638</txnID>
    <date>2/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3639</txnID>
    <date>10/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3640</txnID>
    <date>10/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3641</txnID>
    <date>10/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3642</txnID>
    <date>8/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3643</txnID>
    <date>5/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3644</txnID>
    <date>10/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3645</txnID>
    <date>2/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3646</txnID>
    <date>10/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3647</txnID>
    <date>3/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3648</txnID>
    <date>12/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3649</txnID>
    <date>7/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3650</txnID>
    <date>2/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3651</txnID>
    <date>10/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3652</txnID>
    <date>9/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3653</txnID>
    <date>9/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3654</txnID>
    <date>4/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3655</txnID>
    <date>10/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3656</txnID>
    <date>7/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3657</txnID>
    <date>2/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3658</txnID>
    <date>9/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3659</txnID>
    <date>8/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3660</txnID>
    <date>11/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3661</txnID>
    <date>10/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3662</txnID>
    <date>8/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3663</txnID>
    <date>4/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3664</txnID>
    <date>4/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3665</txnID>
    <date>10/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3666</txnID>
    <date>8/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3667</txnID>
    <date>8/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3668</txnID>
    <date>2/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3669</txnID>
    <date>7/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3670</txnID>
    <date>7/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3671</txnID>
    <date>1/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3672</txnID>
    <date>9/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3673</txnID>
    <date>4/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3674</txnID>
    <date>10/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3675</txnID>
    <date>2/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3676</txnID>
    <date>3/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3677</txnID>
    <date>9/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3678</txnID>
    <date>8/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3679</txnID>
    <date>10/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3680</txnID>
    <date>6/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3681</txnID>
    <date>6/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3682</txnID>
    <date>6/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3683</txnID>
    <date>2/5/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3684</txnID>
    <date>9/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3685</txnID>
    <date>4/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3686</txnID>
    <date>11/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3687</txnID>
    <date>2/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3688</txnID>
    <date>1/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3689</txnID>
    <date>9/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3690</txnID>
    <date>8/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3691</txnID>
    <date>4/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3692</txnID>
    <date>8/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3693</txnID>
    <date>1/1/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3694</txnID>
    <date>2/1/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3695</txnID>
    <date>9/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3696</txnID>
    <date>12/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3697</txnID>
    <date>2/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3698</txnID>
    <date>3/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3699</txnID>
    <date>11/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3700</txnID>
    <date>2/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3701</txnID>
    <date>7/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3702</txnID>
    <date>9/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3703</txnID>
    <date>1/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3704</txnID>
    <date>3/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3705</txnID>
    <date>7/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3706</txnID>
    <date>7/14/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3707</txnID>
    <date>6/27/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3708</txnID>
    <date>1/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3709</txnID>
    <date>2/21/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3710</txnID>
    <date>11/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3711</txnID>
    <date>4/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3712</txnID>
    <date>9/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3713</txnID>
    <date>9/17/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3714</txnID>
    <date>3/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3715</txnID>
    <date>8/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3716</txnID>
    <date>12/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3717</txnID>
    <date>10/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3718</txnID>
    <date>2/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3719</txnID>
    <date>8/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3720</txnID>
    <date>8/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3721</txnID>
    <date>7/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3722</txnID>
    <date>7/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3723</txnID>
    <date>11/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3724</txnID>
    <date>9/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3725</txnID>
    <date>4/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3726</txnID>
    <date>8/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3727</txnID>
    <date>12/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3728</txnID>
    <date>2/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3729</txnID>
    <date>6/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3730</txnID>
    <date>6/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3731</txnID>
    <date>2/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3732</txnID>
    <date>7/7/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3733</txnID>
    <date>2/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3734</txnID>
    <date>11/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3735</txnID>
    <date>8/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3736</txnID>
    <date>11/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3737</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3738</txnID>
    <date>9/13/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3739</txnID>
    <date>4/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3740</txnID>
    <date>6/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3741</txnID>
    <date>6/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3742</txnID>
    <date>6/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3743</txnID>
    <date>12/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3744</txnID>
    <date>5/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3745</txnID>
    <date>10/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3746</txnID>
    <date>7/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3747</txnID>
    <date>8/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3748</txnID>
    <date>5/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3749</txnID>
    <date>11/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3750</txnID>
    <date>5/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3751</txnID>
    <date>4/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3752</txnID>
    <date>8/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3753</txnID>
    <date>7/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3754</txnID>
    <date>10/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3755</txnID>
    <date>8/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3756</txnID>
    <date>5/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3757</txnID>
    <date>9/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3758</txnID>
    <date>10/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3759</txnID>
    <date>11/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3760</txnID>
    <date>12/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3761</txnID>
    <date>12/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3762</txnID>
    <date>3/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3763</txnID>
    <date>4/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3764</txnID>
    <date>9/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3765</txnID>
    <date>2/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3766</txnID>
    <date>8/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3767</txnID>
    <date>11/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3768</txnID>
    <date>1/10/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3769</txnID>
    <date>8/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3770</txnID>
    <date>6/2/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3771</txnID>
    <date>9/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3772</txnID>
    <date>9/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3773</txnID>
    <date>5/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3774</txnID>
    <date>2/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3775</txnID>
    <date>3/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3776</txnID>
    <date>8/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3777</txnID>
    <date>4/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3778</txnID>
    <date>4/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3779</txnID>
    <date>12/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3780</txnID>
    <date>4/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3781</txnID>
    <date>11/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3782</txnID>
    <date>6/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3783</txnID>
    <date>10/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3784</txnID>
    <date>7/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3785</txnID>
    <date>4/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3786</txnID>
    <date>12/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3787</txnID>
    <date>9/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3788</txnID>
    <date>1/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3789</txnID>
    <date>8/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3790</txnID>
    <date>10/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3791</txnID>
    <date>1/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3792</txnID>
    <date>5/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3793</txnID>
    <date>3/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3794</txnID>
    <date>7/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3795</txnID>
    <date>4/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3796</txnID>
    <date>7/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3797</txnID>
    <date>8/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3798</txnID>
    <date>6/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3799</txnID>
    <date>9/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3800</txnID>
    <date>9/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3801</txnID>
    <date>5/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3802</txnID>
    <date>3/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3803</txnID>
    <date>2/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3804</txnID>
    <date>2/15/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3805</txnID>
    <date>2/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3806</txnID>
    <date>1/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3807</txnID>
    <date>3/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3808</txnID>
    <date>6/7/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3809</txnID>
    <date>3/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3810</txnID>
    <date>2/13/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3811</txnID>
    <date>4/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3812</txnID>
    <date>5/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3813</txnID>
    <date>10/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3814</txnID>
    <date>1/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3815</txnID>
    <date>9/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3816</txnID>
    <date>9/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3817</txnID>
    <date>8/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3818</txnID>
    <date>4/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3819</txnID>
    <date>9/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3820</txnID>
    <date>9/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3821</txnID>
    <date>9/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3822</txnID>
    <date>10/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3823</txnID>
    <date>6/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3824</txnID>
    <date>4/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3825</txnID>
    <date>10/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3826</txnID>
    <date>1/7/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3827</txnID>
    <date>3/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3828</txnID>
    <date>4/17/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3829</txnID>
    <date>1/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3830</txnID>
    <date>11/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3831</txnID>
    <date>2/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3832</txnID>
    <date>3/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3833</txnID>
    <date>12/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3834</txnID>
    <date>12/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3835</txnID>
    <date>5/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3836</txnID>
    <date>2/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3837</txnID>
    <date>6/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3838</txnID>
    <date>9/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3839</txnID>
    <date>3/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3840</txnID>
    <date>11/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3841</txnID>
    <date>7/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3842</txnID>
    <date>9/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3843</txnID>
    <date>1/17/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3844</txnID>
    <date>8/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3845</txnID>
    <date>8/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3846</txnID>
    <date>6/23/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3847</txnID>
    <date>10/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3848</txnID>
    <date>7/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3849</txnID>
    <date>4/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3850</txnID>
    <date>5/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3851</txnID>
    <date>7/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3852</txnID>
    <date>5/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3853</txnID>
    <date>7/14/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3854</txnID>
    <date>11/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3855</txnID>
    <date>1/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3856</txnID>
    <date>9/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3857</txnID>
    <date>7/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3858</txnID>
    <date>10/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3859</txnID>
    <date>6/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3860</txnID>
    <date>10/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3861</txnID>
    <date>4/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3862</txnID>
    <date>8/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3863</txnID>
    <date>11/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3864</txnID>
    <date>6/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3865</txnID>
    <date>5/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3866</txnID>
    <date>8/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3867</txnID>
    <date>10/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3868</txnID>
    <date>2/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3869</txnID>
    <date>11/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3870</txnID>
    <date>3/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3871</txnID>
    <date>11/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3872</txnID>
    <date>5/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3873</txnID>
    <date>2/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3874</txnID>
    <date>2/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3875</txnID>
    <date>9/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3876</txnID>
    <date>4/8/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3877</txnID>
    <date>7/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3878</txnID>
    <date>10/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3879</txnID>
    <date>12/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3880</txnID>
    <date>4/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3881</txnID>
    <date>8/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3882</txnID>
    <date>8/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3883</txnID>
    <date>3/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3884</txnID>
    <date>10/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3885</txnID>
    <date>3/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3886</txnID>
    <date>11/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3887</txnID>
    <date>8/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3888</txnID>
    <date>7/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3889</txnID>
    <date>2/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3890</txnID>
    <date>10/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3891</txnID>
    <date>4/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3892</txnID>
    <date>8/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3893</txnID>
    <date>9/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3894</txnID>
    <date>10/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3895</txnID>
    <date>11/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3896</txnID>
    <date>11/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3897</txnID>
    <date>10/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3898</txnID>
    <date>11/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3899</txnID>
    <date>9/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3900</txnID>
    <date>6/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3901</txnID>
    <date>10/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3902</txnID>
    <date>8/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3903</txnID>
    <date>8/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3904</txnID>
    <date>5/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3905</txnID>
    <date>11/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3906</txnID>
    <date>11/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3907</txnID>
    <date>7/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3908</txnID>
    <date>9/9/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3909</txnID>
    <date>11/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3910</txnID>
    <date>10/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3911</txnID>
    <date>10/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3912</txnID>
    <date>11/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3913</txnID>
    <date>3/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3914</txnID>
    <date>12/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3915</txnID>
    <date>10/1/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3916</txnID>
    <date>11/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3917</txnID>
    <date>2/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3918</txnID>
    <date>10/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3919</txnID>
    <date>9/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3920</txnID>
    <date>3/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3921</txnID>
    <date>1/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3922</txnID>
    <date>11/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3923</txnID>
    <date>4/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3924</txnID>
    <date>8/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3925</txnID>
    <date>11/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3926</txnID>
    <date>3/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3927</txnID>
    <date>1/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3928</txnID>
    <date>6/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3929</txnID>
    <date>7/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3930</txnID>
    <date>2/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3931</txnID>
    <date>2/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3932</txnID>
    <date>6/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3933</txnID>
    <date>5/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3934</txnID>
    <date>5/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3935</txnID>
    <date>6/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3936</txnID>
    <date>3/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3937</txnID>
    <date>6/14/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3938</txnID>
    <date>5/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3939</txnID>
    <date>9/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3940</txnID>
    <date>8/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3941</txnID>
    <date>1/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3942</txnID>
    <date>12/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3943</txnID>
    <date>7/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3944</txnID>
    <date>7/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3945</txnID>
    <date>9/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3946</txnID>
    <date>4/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3947</txnID>
    <date>6/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3948</txnID>
    <date>8/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3949</txnID>
    <date>10/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3950</txnID>
    <date>12/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3951</txnID>
    <date>6/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3952</txnID>
    <date>9/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3953</txnID>
    <date>8/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3954</txnID>
    <date>7/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3955</txnID>
    <date>1/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3956</txnID>
    <date>5/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3957</txnID>
    <date>8/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3958</txnID>
    <date>8/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3959</txnID>
    <date>5/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3960</txnID>
    <date>10/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3961</txnID>
    <date>10/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3962</txnID>
    <date>12/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3963</txnID>
    <date>6/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3964</txnID>
    <date>9/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3965</txnID>
    <date>3/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3966</txnID>
    <date>4/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3967</txnID>
    <date>3/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3968</txnID>
    <date>7/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3969</txnID>
    <date>7/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3970</txnID>
    <date>5/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3971</txnID>
    <date>8/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3972</txnID>
    <date>11/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3973</txnID>
    <date>6/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3974</txnID>
    <date>9/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3975</txnID>
    <date>11/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>3976</txnID>
    <date>2/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3977</txnID>
    <date>7/1/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3978</txnID>
    <date>3/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3979</txnID>
    <date>2/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3980</txnID>
    <date>11/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3981</txnID>
    <date>5/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3982</txnID>
    <date>8/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3983</txnID>
    <date>7/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3984</txnID>
    <date>4/19/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3985</txnID>
    <date>5/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>3986</txnID>
    <date>7/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3987</txnID>
    <date>4/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3988</txnID>
    <date>11/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3989</txnID>
    <date>2/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3990</txnID>
    <date>7/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3991</txnID>
    <date>5/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3992</txnID>
    <date>6/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3993</txnID>
    <date>11/4/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3994</txnID>
    <date>8/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>3995</txnID>
    <date>6/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3996</txnID>
    <date>11/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>3997</txnID>
    <date>6/16/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>3998</txnID>
    <date>7/24/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>3999</txnID>
    <date>9/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4000</txnID>
    <date>1/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4001</txnID>
    <date>12/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4002</txnID>
    <date>6/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4003</txnID>
    <date>10/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4004</txnID>
    <date>10/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4005</txnID>
    <date>7/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4006</txnID>
    <date>2/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4007</txnID>
    <date>2/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4008</txnID>
    <date>10/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4009</txnID>
    <date>12/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4010</txnID>
    <date>6/27/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4011</txnID>
    <date>11/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4012</txnID>
    <date>10/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4013</txnID>
    <date>4/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4014</txnID>
    <date>4/25/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4015</txnID>
    <date>7/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4016</txnID>
    <date>3/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4017</txnID>
    <date>2/14/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4018</txnID>
    <date>5/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4019</txnID>
    <date>7/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4020</txnID>
    <date>8/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4021</txnID>
    <date>2/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4022</txnID>
    <date>6/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4023</txnID>
    <date>5/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4024</txnID>
    <date>2/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4025</txnID>
    <date>5/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4026</txnID>
    <date>10/16/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4027</txnID>
    <date>7/1/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4028</txnID>
    <date>4/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4029</txnID>
    <date>9/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4030</txnID>
    <date>12/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4031</txnID>
    <date>8/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4032</txnID>
    <date>9/15/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4033</txnID>
    <date>10/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4034</txnID>
    <date>8/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4035</txnID>
    <date>3/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4036</txnID>
    <date>10/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4037</txnID>
    <date>7/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4038</txnID>
    <date>4/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4039</txnID>
    <date>8/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4040</txnID>
    <date>6/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4041</txnID>
    <date>10/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4042</txnID>
    <date>12/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4043</txnID>
    <date>9/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4044</txnID>
    <date>9/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4045</txnID>
    <date>1/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4046</txnID>
    <date>10/9/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4047</txnID>
    <date>11/18/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4048</txnID>
    <date>2/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4049</txnID>
    <date>1/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4050</txnID>
    <date>2/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4051</txnID>
    <date>5/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4052</txnID>
    <date>10/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4053</txnID>
    <date>12/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4054</txnID>
    <date>10/6/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4055</txnID>
    <date>4/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4056</txnID>
    <date>8/20/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>300</qty>
    <amount>216</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4057</txnID>
    <date>7/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4058</txnID>
    <date>1/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4059</txnID>
    <date>9/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4060</txnID>
    <date>2/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4061</txnID>
    <date>3/17/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4062</txnID>
    <date>7/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4063</txnID>
    <date>1/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4064</txnID>
    <date>3/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4065</txnID>
    <date>8/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4066</txnID>
    <date>12/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4067</txnID>
    <date>11/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4068</txnID>
    <date>5/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4069</txnID>
    <date>6/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4070</txnID>
    <date>7/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4071</txnID>
    <date>12/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4072</txnID>
    <date>11/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4073</txnID>
    <date>7/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4074</txnID>
    <date>2/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4075</txnID>
    <date>11/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4076</txnID>
    <date>6/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4077</txnID>
    <date>3/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4078</txnID>
    <date>4/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4079</txnID>
    <date>12/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4080</txnID>
    <date>9/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4081</txnID>
    <date>9/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4082</txnID>
    <date>11/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4083</txnID>
    <date>10/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4084</txnID>
    <date>11/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4085</txnID>
    <date>3/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4086</txnID>
    <date>7/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4087</txnID>
    <date>12/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4088</txnID>
    <date>11/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4089</txnID>
    <date>4/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4090</txnID>
    <date>4/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4091</txnID>
    <date>5/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4092</txnID>
    <date>2/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4093</txnID>
    <date>10/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4094</txnID>
    <date>4/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4095</txnID>
    <date>9/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4096</txnID>
    <date>1/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4097</txnID>
    <date>5/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4098</txnID>
    <date>12/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4099</txnID>
    <date>11/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4100</txnID>
    <date>7/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4101</txnID>
    <date>2/1/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4102</txnID>
    <date>3/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4103</txnID>
    <date>5/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4104</txnID>
    <date>1/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4105</txnID>
    <date>4/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4106</txnID>
    <date>12/27/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4107</txnID>
    <date>3/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4108</txnID>
    <date>6/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4109</txnID>
    <date>12/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4110</txnID>
    <date>4/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4111</txnID>
    <date>10/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4112</txnID>
    <date>11/28/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4113</txnID>
    <date>8/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4114</txnID>
    <date>4/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4115</txnID>
    <date>8/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4116</txnID>
    <date>7/28/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4117</txnID>
    <date>3/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4118</txnID>
    <date>6/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4119</txnID>
    <date>9/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4120</txnID>
    <date>7/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4121</txnID>
    <date>2/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4122</txnID>
    <date>7/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4123</txnID>
    <date>2/1/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4124</txnID>
    <date>9/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4125</txnID>
    <date>2/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4126</txnID>
    <date>10/15/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4127</txnID>
    <date>3/14/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4128</txnID>
    <date>1/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4129</txnID>
    <date>2/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4130</txnID>
    <date>10/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4131</txnID>
    <date>11/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4132</txnID>
    <date>4/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4133</txnID>
    <date>1/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4134</txnID>
    <date>3/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4135</txnID>
    <date>10/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4136</txnID>
    <date>11/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4137</txnID>
    <date>9/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4138</txnID>
    <date>3/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4139</txnID>
    <date>6/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4140</txnID>
    <date>2/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4141</txnID>
    <date>11/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4142</txnID>
    <date>12/6/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4143</txnID>
    <date>9/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4144</txnID>
    <date>3/28/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4145</txnID>
    <date>8/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4146</txnID>
    <date>4/16/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4147</txnID>
    <date>9/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4148</txnID>
    <date>2/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4149</txnID>
    <date>6/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4150</txnID>
    <date>7/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4151</txnID>
    <date>6/18/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4152</txnID>
    <date>2/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4153</txnID>
    <date>7/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4154</txnID>
    <date>2/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4155</txnID>
    <date>10/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4156</txnID>
    <date>7/17/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4157</txnID>
    <date>12/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4158</txnID>
    <date>1/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4159</txnID>
    <date>2/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4160</txnID>
    <date>12/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4161</txnID>
    <date>11/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4162</txnID>
    <date>6/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4163</txnID>
    <date>1/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4164</txnID>
    <date>11/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4165</txnID>
    <date>11/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4166</txnID>
    <date>5/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4167</txnID>
    <date>6/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4168</txnID>
    <date>8/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4169</txnID>
    <date>4/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4170</txnID>
    <date>10/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4171</txnID>
    <date>2/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4172</txnID>
    <date>11/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4173</txnID>
    <date>6/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4174</txnID>
    <date>5/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4175</txnID>
    <date>6/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4176</txnID>
    <date>5/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4177</txnID>
    <date>7/20/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4178</txnID>
    <date>2/15/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4179</txnID>
    <date>2/20/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4180</txnID>
    <date>9/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4181</txnID>
    <date>3/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4182</txnID>
    <date>9/28/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4183</txnID>
    <date>2/23/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4184</txnID>
    <date>6/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4185</txnID>
    <date>4/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4186</txnID>
    <date>3/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4187</txnID>
    <date>2/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4188</txnID>
    <date>1/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4189</txnID>
    <date>11/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4190</txnID>
    <date>4/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4191</txnID>
    <date>7/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4192</txnID>
    <date>5/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4193</txnID>
    <date>11/20/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4194</txnID>
    <date>7/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4195</txnID>
    <date>2/25/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4196</txnID>
    <date>11/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4197</txnID>
    <date>6/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4198</txnID>
    <date>1/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4199</txnID>
    <date>9/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4200</txnID>
    <date>6/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4201</txnID>
    <date>6/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4202</txnID>
    <date>1/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1200</qty>
    <amount>4644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4203</txnID>
    <date>10/9/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4204</txnID>
    <date>11/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4205</txnID>
    <date>1/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4206</txnID>
    <date>8/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4207</txnID>
    <date>8/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4208</txnID>
    <date>3/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4209</txnID>
    <date>5/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4210</txnID>
    <date>10/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4211</txnID>
    <date>8/25/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4212</txnID>
    <date>2/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4213</txnID>
    <date>5/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4214</txnID>
    <date>2/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4215</txnID>
    <date>4/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4216</txnID>
    <date>4/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4217</txnID>
    <date>7/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4218</txnID>
    <date>9/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4219</txnID>
    <date>1/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4220</txnID>
    <date>7/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4221</txnID>
    <date>9/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4222</txnID>
    <date>4/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4223</txnID>
    <date>4/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4224</txnID>
    <date>5/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4225</txnID>
    <date>1/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4226</txnID>
    <date>9/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4227</txnID>
    <date>10/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4228</txnID>
    <date>7/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4229</txnID>
    <date>11/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4230</txnID>
    <date>6/28/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4231</txnID>
    <date>9/26/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4232</txnID>
    <date>6/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4233</txnID>
    <date>6/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4234</txnID>
    <date>11/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4235</txnID>
    <date>3/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4236</txnID>
    <date>5/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4237</txnID>
    <date>7/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4238</txnID>
    <date>11/21/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4239</txnID>
    <date>8/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4240</txnID>
    <date>11/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4241</txnID>
    <date>3/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4242</txnID>
    <date>10/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4243</txnID>
    <date>12/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4244</txnID>
    <date>6/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4245</txnID>
    <date>10/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4246</txnID>
    <date>1/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4247</txnID>
    <date>4/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4248</txnID>
    <date>3/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4249</txnID>
    <date>11/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4250</txnID>
    <date>12/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4251</txnID>
    <date>1/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4252</txnID>
    <date>8/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4253</txnID>
    <date>8/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4254</txnID>
    <date>10/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4255</txnID>
    <date>9/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4256</txnID>
    <date>7/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4257</txnID>
    <date>11/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4258</txnID>
    <date>9/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4259</txnID>
    <date>1/22/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4260</txnID>
    <date>2/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4261</txnID>
    <date>2/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4262</txnID>
    <date>8/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4263</txnID>
    <date>10/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4264</txnID>
    <date>5/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4265</txnID>
    <date>9/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4266</txnID>
    <date>10/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>100</qty>
    <amount>282</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4267</txnID>
    <date>6/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4268</txnID>
    <date>10/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4269</txnID>
    <date>7/5/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4270</txnID>
    <date>3/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4271</txnID>
    <date>2/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4272</txnID>
    <date>10/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4273</txnID>
    <date>12/22/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4274</txnID>
    <date>1/6/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4275</txnID>
    <date>5/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4276</txnID>
    <date>3/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4277</txnID>
    <date>3/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4278</txnID>
    <date>9/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4279</txnID>
    <date>4/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4280</txnID>
    <date>8/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4281</txnID>
    <date>1/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4282</txnID>
    <date>3/25/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4283</txnID>
    <date>10/24/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4284</txnID>
    <date>10/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4285</txnID>
    <date>4/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>2000</qty>
    <amount>2880</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4286</txnID>
    <date>3/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4287</txnID>
    <date>9/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4288</txnID>
    <date>10/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4289</txnID>
    <date>11/28/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4290</txnID>
    <date>4/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4291</txnID>
    <date>8/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4292</txnID>
    <date>2/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4293</txnID>
    <date>9/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4294</txnID>
    <date>6/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4295</txnID>
    <date>9/8/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4296</txnID>
    <date>4/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4297</txnID>
    <date>4/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4298</txnID>
    <date>3/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4299</txnID>
    <date>5/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4300</txnID>
    <date>2/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4301</txnID>
    <date>1/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4302</txnID>
    <date>7/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4303</txnID>
    <date>10/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4304</txnID>
    <date>3/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4305</txnID>
    <date>5/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4306</txnID>
    <date>4/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4307</txnID>
    <date>3/27/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4308</txnID>
    <date>9/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4309</txnID>
    <date>4/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4310</txnID>
    <date>7/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4311</txnID>
    <date>4/5/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4312</txnID>
    <date>12/20/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4313</txnID>
    <date>8/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4314</txnID>
    <date>9/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4315</txnID>
    <date>8/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4316</txnID>
    <date>8/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4317</txnID>
    <date>11/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4318</txnID>
    <date>6/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4319</txnID>
    <date>12/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4320</txnID>
    <date>10/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4321</txnID>
    <date>7/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4322</txnID>
    <date>3/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4323</txnID>
    <date>3/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4324</txnID>
    <date>11/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4325</txnID>
    <date>9/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4326</txnID>
    <date>8/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4327</txnID>
    <date>8/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4328</txnID>
    <date>10/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4329</txnID>
    <date>9/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4330</txnID>
    <date>12/28/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4331</txnID>
    <date>2/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4332</txnID>
    <date>7/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4333</txnID>
    <date>8/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4334</txnID>
    <date>4/23/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4335</txnID>
    <date>4/8/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4336</txnID>
    <date>11/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4337</txnID>
    <date>3/11/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4338</txnID>
    <date>2/16/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4339</txnID>
    <date>2/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4340</txnID>
    <date>6/14/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4341</txnID>
    <date>8/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4342</txnID>
    <date>7/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4343</txnID>
    <date>3/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4344</txnID>
    <date>8/2/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4345</txnID>
    <date>6/25/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4346</txnID>
    <date>3/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4347</txnID>
    <date>3/6/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4348</txnID>
    <date>7/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4349</txnID>
    <date>11/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4350</txnID>
    <date>9/24/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4351</txnID>
    <date>5/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4352</txnID>
    <date>6/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4353</txnID>
    <date>9/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4354</txnID>
    <date>5/15/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4355</txnID>
    <date>12/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4356</txnID>
    <date>2/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4357</txnID>
    <date>3/17/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4358</txnID>
    <date>3/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4359</txnID>
    <date>11/13/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4360</txnID>
    <date>2/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4361</txnID>
    <date>3/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4362</txnID>
    <date>5/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4363</txnID>
    <date>10/7/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4364</txnID>
    <date>8/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4365</txnID>
    <date>4/4/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4366</txnID>
    <date>5/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4367</txnID>
    <date>4/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4368</txnID>
    <date>8/10/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4369</txnID>
    <date>10/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4370</txnID>
    <date>9/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4371</txnID>
    <date>2/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4372</txnID>
    <date>3/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4373</txnID>
    <date>4/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4374</txnID>
    <date>5/1/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4375</txnID>
    <date>11/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4376</txnID>
    <date>7/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4377</txnID>
    <date>3/2/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4378</txnID>
    <date>9/19/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4379</txnID>
    <date>8/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4380</txnID>
    <date>11/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4381</txnID>
    <date>7/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4382</txnID>
    <date>9/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4383</txnID>
    <date>3/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4384</txnID>
    <date>7/21/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4385</txnID>
    <date>10/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4386</txnID>
    <date>9/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4387</txnID>
    <date>6/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4388</txnID>
    <date>12/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4389</txnID>
    <date>5/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>100</qty>
    <amount>187</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4390</txnID>
    <date>10/8/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4391</txnID>
    <date>9/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4392</txnID>
    <date>9/25/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4393</txnID>
    <date>4/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4394</txnID>
    <date>5/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4395</txnID>
    <date>12/8/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4396</txnID>
    <date>7/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4397</txnID>
    <date>4/27/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4398</txnID>
    <date>8/13/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4399</txnID>
    <date>10/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4400</txnID>
    <date>7/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4401</txnID>
    <date>6/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4402</txnID>
    <date>12/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4403</txnID>
    <date>11/8/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4404</txnID>
    <date>10/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4405</txnID>
    <date>3/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4406</txnID>
    <date>5/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4407</txnID>
    <date>4/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4408</txnID>
    <date>7/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4409</txnID>
    <date>7/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4410</txnID>
    <date>2/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4411</txnID>
    <date>7/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4412</txnID>
    <date>2/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4413</txnID>
    <date>12/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4414</txnID>
    <date>5/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4415</txnID>
    <date>4/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4416</txnID>
    <date>2/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4417</txnID>
    <date>4/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4418</txnID>
    <date>11/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4419</txnID>
    <date>6/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4420</txnID>
    <date>1/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4421</txnID>
    <date>9/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4422</txnID>
    <date>3/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4423</txnID>
    <date>7/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4424</txnID>
    <date>4/1/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4425</txnID>
    <date>6/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4426</txnID>
    <date>1/11/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4427</txnID>
    <date>6/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4428</txnID>
    <date>10/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4429</txnID>
    <date>3/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4430</txnID>
    <date>3/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4431</txnID>
    <date>8/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4432</txnID>
    <date>10/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4433</txnID>
    <date>7/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4434</txnID>
    <date>5/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4435</txnID>
    <date>12/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4436</txnID>
    <date>8/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4437</txnID>
    <date>10/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4438</txnID>
    <date>10/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4439</txnID>
    <date>8/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4440</txnID>
    <date>10/18/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4441</txnID>
    <date>4/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4442</txnID>
    <date>9/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4443</txnID>
    <date>1/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4444</txnID>
    <date>10/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4445</txnID>
    <date>1/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4446</txnID>
    <date>8/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4447</txnID>
    <date>3/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4448</txnID>
    <date>8/24/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4449</txnID>
    <date>12/8/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4450</txnID>
    <date>6/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4451</txnID>
    <date>11/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4452</txnID>
    <date>4/18/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4453</txnID>
    <date>4/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4454</txnID>
    <date>8/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4455</txnID>
    <date>5/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4456</txnID>
    <date>7/5/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4457</txnID>
    <date>11/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4458</txnID>
    <date>11/11/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4459</txnID>
    <date>3/7/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4460</txnID>
    <date>12/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4461</txnID>
    <date>4/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4462</txnID>
    <date>8/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4463</txnID>
    <date>10/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4464</txnID>
    <date>4/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4465</txnID>
    <date>8/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4466</txnID>
    <date>9/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4467</txnID>
    <date>4/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4468</txnID>
    <date>3/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4469</txnID>
    <date>7/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4470</txnID>
    <date>6/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4471</txnID>
    <date>10/11/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4472</txnID>
    <date>5/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4473</txnID>
    <date>11/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4474</txnID>
    <date>3/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4475</txnID>
    <date>4/22/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4476</txnID>
    <date>8/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4477</txnID>
    <date>3/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4478</txnID>
    <date>3/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4479</txnID>
    <date>2/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4480</txnID>
    <date>1/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4481</txnID>
    <date>7/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4482</txnID>
    <date>7/14/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4483</txnID>
    <date>4/24/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4484</txnID>
    <date>4/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4485</txnID>
    <date>6/14/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4486</txnID>
    <date>5/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4487</txnID>
    <date>8/21/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4488</txnID>
    <date>9/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4489</txnID>
    <date>8/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4490</txnID>
    <date>2/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4491</txnID>
    <date>9/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4492</txnID>
    <date>6/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4493</txnID>
    <date>6/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4494</txnID>
    <date>3/18/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4495</txnID>
    <date>7/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>1700</qty>
    <amount>1224</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4496</txnID>
    <date>6/4/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4497</txnID>
    <date>8/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4498</txnID>
    <date>9/9/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4499</txnID>
    <date>4/3/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4500</txnID>
    <date>11/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4501</txnID>
    <date>10/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4502</txnID>
    <date>7/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4503</txnID>
    <date>10/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4504</txnID>
    <date>12/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4505</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4506</txnID>
    <date>7/26/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4507</txnID>
    <date>1/6/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4508</txnID>
    <date>2/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4509</txnID>
    <date>8/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4510</txnID>
    <date>11/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4511</txnID>
    <date>1/15/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4512</txnID>
    <date>5/3/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4513</txnID>
    <date>10/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4514</txnID>
    <date>1/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4515</txnID>
    <date>5/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4516</txnID>
    <date>9/16/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4517</txnID>
    <date>9/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4518</txnID>
    <date>12/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4519</txnID>
    <date>7/3/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4520</txnID>
    <date>5/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4521</txnID>
    <date>3/14/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4522</txnID>
    <date>2/22/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4523</txnID>
    <date>4/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4524</txnID>
    <date>11/3/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4525</txnID>
    <date>7/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1100</qty>
    <amount>1012</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4526</txnID>
    <date>3/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4527</txnID>
    <date>9/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4528</txnID>
    <date>10/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4529</txnID>
    <date>9/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4530</txnID>
    <date>10/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4531</txnID>
    <date>1/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4532</txnID>
    <date>3/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4533</txnID>
    <date>2/23/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4534</txnID>
    <date>5/27/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4535</txnID>
    <date>6/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4536</txnID>
    <date>6/1/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4537</txnID>
    <date>11/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4538</txnID>
    <date>3/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>400</qty>
    <amount>1128</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4539</txnID>
    <date>5/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4540</txnID>
    <date>11/12/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4541</txnID>
    <date>5/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4542</txnID>
    <date>7/25/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4543</txnID>
    <date>2/28/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4544</txnID>
    <date>1/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4545</txnID>
    <date>4/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4546</txnID>
    <date>7/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4547</txnID>
    <date>7/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4548</txnID>
    <date>8/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4549</txnID>
    <date>1/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>600</qty>
    <amount>1122</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4550</txnID>
    <date>6/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4551</txnID>
    <date>11/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4552</txnID>
    <date>7/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4553</txnID>
    <date>10/13/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4554</txnID>
    <date>7/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4555</txnID>
    <date>7/24/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4556</txnID>
    <date>12/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4557</txnID>
    <date>9/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4558</txnID>
    <date>12/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4559</txnID>
    <date>11/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4560</txnID>
    <date>6/2/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>100</qty>
    <amount>123</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4561</txnID>
    <date>9/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4562</txnID>
    <date>6/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4563</txnID>
    <date>9/2/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4564</txnID>
    <date>3/20/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4565</txnID>
    <date>4/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4566</txnID>
    <date>8/10/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4567</txnID>
    <date>5/8/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4568</txnID>
    <date>7/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4569</txnID>
    <date>8/24/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4570</txnID>
    <date>6/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4571</txnID>
    <date>6/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4572</txnID>
    <date>4/27/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4573</txnID>
    <date>10/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4574</txnID>
    <date>5/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4575</txnID>
    <date>7/7/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4576</txnID>
    <date>5/13/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4577</txnID>
    <date>3/23/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4578</txnID>
    <date>5/23/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4579</txnID>
    <date>6/26/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4580</txnID>
    <date>5/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4581</txnID>
    <date>3/16/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4582</txnID>
    <date>3/12/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4583</txnID>
    <date>11/26/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4584</txnID>
    <date>4/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4585</txnID>
    <date>2/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4586</txnID>
    <date>1/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4587</txnID>
    <date>2/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4588</txnID>
    <date>1/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4589</txnID>
    <date>7/19/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4590</txnID>
    <date>10/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4591</txnID>
    <date>7/4/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4592</txnID>
    <date>8/5/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4593</txnID>
    <date>5/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4594</txnID>
    <date>2/6/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4595</txnID>
    <date>2/17/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4596</txnID>
    <date>1/27/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4597</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4598</txnID>
    <date>7/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4599</txnID>
    <date>9/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4600</txnID>
    <date>1/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4601</txnID>
    <date>2/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4602</txnID>
    <date>1/9/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4603</txnID>
    <date>4/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4604</txnID>
    <date>10/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4605</txnID>
    <date>10/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4606</txnID>
    <date>1/18/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4607</txnID>
    <date>8/2/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4608</txnID>
    <date>9/22/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1200</qty>
    <amount>864</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4609</txnID>
    <date>4/9/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4610</txnID>
    <date>2/24/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4611</txnID>
    <date>5/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4612</txnID>
    <date>5/5/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1000</qty>
    <amount>720</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4613</txnID>
    <date>6/21/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4614</txnID>
    <date>8/27/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4615</txnID>
    <date>9/6/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4616</txnID>
    <date>6/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4617</txnID>
    <date>11/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4618</txnID>
    <date>10/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4619</txnID>
    <date>6/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4620</txnID>
    <date>2/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4621</txnID>
    <date>5/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4622</txnID>
    <date>10/7/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>2000</qty>
    <amount>80</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4623</txnID>
    <date>12/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4624</txnID>
    <date>10/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4625</txnID>
    <date>9/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4626</txnID>
    <date>3/19/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4627</txnID>
    <date>1/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4628</txnID>
    <date>5/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4629</txnID>
    <date>1/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4630</txnID>
    <date>2/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4631</txnID>
    <date>10/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4632</txnID>
    <date>6/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4633</txnID>
    <date>6/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4634</txnID>
    <date>2/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1700</qty>
    <amount>6579</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4635</txnID>
    <date>12/5/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4636</txnID>
    <date>4/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>1800</qty>
    <amount>2214</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4637</txnID>
    <date>10/22/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4638</txnID>
    <date>9/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4639</txnID>
    <date>6/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4640</txnID>
    <date>11/11/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4641</txnID>
    <date>5/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4642</txnID>
    <date>12/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4643</txnID>
    <date>2/6/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>700</qty>
    <amount>28</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4644</txnID>
    <date>1/22/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4645</txnID>
    <date>4/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4646</txnID>
    <date>3/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4647</txnID>
    <date>6/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4648</txnID>
    <date>11/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>800</qty>
    <amount>736</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4649</txnID>
    <date>4/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4650</txnID>
    <date>1/26/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4651</txnID>
    <date>4/24/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4652</txnID>
    <date>7/20/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4653</txnID>
    <date>11/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4654</txnID>
    <date>4/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4655</txnID>
    <date>1/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4656</txnID>
    <date>4/21/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4657</txnID>
    <date>12/16/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4658</txnID>
    <date>3/15/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4659</txnID>
    <date>10/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4660</txnID>
    <date>4/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4661</txnID>
    <date>1/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1600</qty>
    <amount>1968</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4662</txnID>
    <date>3/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4663</txnID>
    <date>8/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1000</qty>
    <amount>1870</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4664</txnID>
    <date>5/27/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4665</txnID>
    <date>11/6/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4666</txnID>
    <date>6/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4667</txnID>
    <date>11/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>100</qty>
    <amount>387</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4668</txnID>
    <date>3/23/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>700</qty>
    <amount>861</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4669</txnID>
    <date>5/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4670</txnID>
    <date>8/1/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4671</txnID>
    <date>2/25/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4672</txnID>
    <date>4/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4673</txnID>
    <date>3/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4674</txnID>
    <date>5/11/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4675</txnID>
    <date>6/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4676</txnID>
    <date>11/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4677</txnID>
    <date>6/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Xipramin</prod>
    <qty>100</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4678</txnID>
    <date>10/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4679</txnID>
    <date>2/11/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1900</qty>
    <amount>2736</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4680</txnID>
    <date>6/25/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4681</txnID>
    <date>5/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4682</txnID>
    <date>5/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4683</txnID>
    <date>12/20/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4684</txnID>
    <date>9/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4685</txnID>
    <date>5/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4686</txnID>
    <date>7/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1700</qty>
    <amount>3179</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4687</txnID>
    <date>12/21/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4688</txnID>
    <date>1/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4689</txnID>
    <date>6/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4690</txnID>
    <date>8/20/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4691</txnID>
    <date>10/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Bhiktarvizem</prod>
    <qty>300</qty>
    <amount>1161</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4692</txnID>
    <date>12/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>2000</qty>
    <amount>7740</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4693</txnID>
    <date>5/4/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4694</txnID>
    <date>2/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4695</txnID>
    <date>1/28/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4696</txnID>
    <date>3/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4697</txnID>
    <date>5/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4698</txnID>
    <date>8/25/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4699</txnID>
    <date>11/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4700</txnID>
    <date>4/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>2000</qty>
    <amount>2460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4701</txnID>
    <date>7/26/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4702</txnID>
    <date>3/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4703</txnID>
    <date>6/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4704</txnID>
    <date>11/6/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4705</txnID>
    <date>9/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4706</txnID>
    <date>11/4/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4707</txnID>
    <date>7/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>200</qty>
    <amount>374</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4708</txnID>
    <date>9/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4709</txnID>
    <date>5/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4710</txnID>
    <date>11/8/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4711</txnID>
    <date>1/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4712</txnID>
    <date>10/28/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>2000</qty>
    <amount>3740</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4713</txnID>
    <date>11/28/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4714</txnID>
    <date>11/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4715</txnID>
    <date>9/2/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4716</txnID>
    <date>10/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4717</txnID>
    <date>7/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4718</txnID>
    <date>4/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4719</txnID>
    <date>8/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4720</txnID>
    <date>3/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4721</txnID>
    <date>2/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4722</txnID>
    <date>2/10/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4723</txnID>
    <date>6/13/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4724</txnID>
    <date>12/21/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4725</txnID>
    <date>4/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4726</txnID>
    <date>5/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4727</txnID>
    <date>11/13/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1600</qty>
    <amount>2304</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4728</txnID>
    <date>2/10/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4729</txnID>
    <date>8/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4730</txnID>
    <date>12/12/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1700</qty>
    <amount>4794</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4731</txnID>
    <date>8/18/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Clobromizen</prod>
    <qty>600</qty>
    <amount>864</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4732</txnID>
    <date>7/7/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4733</txnID>
    <date>7/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4734</txnID>
    <date>8/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4735</txnID>
    <date>6/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4736</txnID>
    <date>11/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4737</txnID>
    <date>2/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4738</txnID>
    <date>3/22/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>1800</qty>
    <amount>5076</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4739</txnID>
    <date>8/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4740</txnID>
    <date>12/15/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>1300</qty>
    <amount>1872</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4741</txnID>
    <date>2/10/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xipramin</prod>
    <qty>400</qty>
    <amount>288</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4742</txnID>
    <date>1/18/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4743</txnID>
    <date>9/14/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4744</txnID>
    <date>5/27/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4745</txnID>
    <date>8/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>400</qty>
    <amount>492</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4746</txnID>
    <date>3/18/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4747</txnID>
    <date>1/2/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4748</txnID>
    <date>5/15/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4749</txnID>
    <date>4/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4750</txnID>
    <date>10/1/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4751</txnID>
    <date>8/4/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4752</txnID>
    <date>2/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4753</txnID>
    <date>5/23/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4754</txnID>
    <date>12/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4755</txnID>
    <date>9/3/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4756</txnID>
    <date>5/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4757</txnID>
    <date>5/19/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1600</qty>
    <amount>6192</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4758</txnID>
    <date>7/28/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4759</txnID>
    <date>2/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4760</txnID>
    <date>4/13/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4761</txnID>
    <date>9/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xinoprozen</prod>
    <qty>1300</qty>
    <amount>3666</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4762</txnID>
    <date>12/17/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1500</qty>
    <amount>5805</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4763</txnID>
    <date>6/12/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4764</txnID>
    <date>5/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>200</qty>
    <amount>144</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4765</txnID>
    <date>3/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>500</qty>
    <amount>1935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4766</txnID>
    <date>9/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4767</txnID>
    <date>4/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4768</txnID>
    <date>2/14/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4769</txnID>
    <date>4/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4770</txnID>
    <date>11/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4771</txnID>
    <date>2/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4772</txnID>
    <date>10/5/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4773</txnID>
    <date>8/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4774</txnID>
    <date>10/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4775</txnID>
    <date>3/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4776</txnID>
    <date>8/20/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4777</txnID>
    <date>5/20/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4778</txnID>
    <date>1/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>500</qty>
    <amount>720</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4779</txnID>
    <date>8/2/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4780</txnID>
    <date>3/5/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4781</txnID>
    <date>4/25/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4782</txnID>
    <date>11/14/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4783</txnID>
    <date>4/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4784</txnID>
    <date>8/13/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1300</qty>
    <amount>5031</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4785</txnID>
    <date>1/17/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1600</qty>
    <amount>2992</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4786</txnID>
    <date>10/12/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4787</txnID>
    <date>9/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4788</txnID>
    <date>10/17/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4789</txnID>
    <date>8/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4790</txnID>
    <date>8/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4791</txnID>
    <date>5/23/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4792</txnID>
    <date>10/28/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4793</txnID>
    <date>11/17/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>400</qty>
    <amount>576</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4794</txnID>
    <date>6/1/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4795</txnID>
    <date>4/27/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4796</txnID>
    <date>9/10/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4797</txnID>
    <date>4/3/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>900</qty>
    <amount>3483</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4798</txnID>
    <date>2/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>400</qty>
    <amount>16</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4799</txnID>
    <date>7/7/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4800</txnID>
    <date>3/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4801</txnID>
    <date>6/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Clobromizen</prod>
    <qty>300</qty>
    <amount>432</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4802</txnID>
    <date>5/28/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4803</txnID>
    <date>4/28/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>900</qty>
    <amount>1107</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4804</txnID>
    <date>1/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4805</txnID>
    <date>8/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4806</txnID>
    <date>5/1/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>1200</qty>
    <amount>1476</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4807</txnID>
    <date>9/7/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4808</txnID>
    <date>12/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4809</txnID>
    <date>4/3/2020</date>
    <cust>Enim PC</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4810</txnID>
    <date>12/26/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4811</txnID>
    <date>9/16/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1400</qty>
    <amount>1722</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4812</txnID>
    <date>10/25/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4813</txnID>
    <date>3/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Alaraphosol</prod>
    <qty>900</qty>
    <amount>828</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4814</txnID>
    <date>9/23/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4815</txnID>
    <date>5/24/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4816</txnID>
    <date>12/15/2020</date>
    <cust>Enim PC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4817</txnID>
    <date>7/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4818</txnID>
    <date>5/22/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>800</qty>
    <amount>3096</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4819</txnID>
    <date>10/22/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>500</qty>
    <amount>1410</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4820</txnID>
    <date>5/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4821</txnID>
    <date>4/21/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4822</txnID>
    <date>3/11/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>1300</qty>
    <amount>936</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4823</txnID>
    <date>7/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4824</txnID>
    <date>3/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4825</txnID>
    <date>6/6/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>1300</qty>
    <amount>52</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4826</txnID>
    <date>2/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4827</txnID>
    <date>5/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>1300</qty>
    <amount>1196</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4828</txnID>
    <date>10/5/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>1400</qty>
    <amount>56</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4829</txnID>
    <date>10/6/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>900</qty>
    <amount>1683</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4830</txnID>
    <date>7/26/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1800</qty>
    <amount>2592</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4831</txnID>
    <date>4/11/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4832</txnID>
    <date>8/27/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>100</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4833</txnID>
    <date>12/13/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4834</txnID>
    <date>1/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4835</txnID>
    <date>2/10/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4836</txnID>
    <date>10/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xipramin</prod>
    <qty>1800</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4837</txnID>
    <date>4/16/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4838</txnID>
    <date>3/12/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4839</txnID>
    <date>9/27/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4840</txnID>
    <date>2/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4841</txnID>
    <date>10/21/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4842</txnID>
    <date>3/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4843</txnID>
    <date>2/27/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4844</txnID>
    <date>2/8/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4845</txnID>
    <date>8/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>600</qty>
    <amount>432</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4846</txnID>
    <date>7/3/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4847</txnID>
    <date>7/24/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4848</txnID>
    <date>4/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4849</txnID>
    <date>6/25/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4850</txnID>
    <date>5/12/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>300</qty>
    <amount>846</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4851</txnID>
    <date>5/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1100</qty>
    <amount>1353</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4852</txnID>
    <date>1/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1900</qty>
    <amount>7353</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4853</txnID>
    <date>5/16/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4854</txnID>
    <date>12/19/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4855</txnID>
    <date>3/19/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4856</txnID>
    <date>12/24/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4857</txnID>
    <date>6/13/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4858</txnID>
    <date>6/25/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4859</txnID>
    <date>4/19/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1800</qty>
    <amount>3366</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4860</txnID>
    <date>10/12/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4861</txnID>
    <date>5/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1400</qty>
    <amount>5418</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4862</txnID>
    <date>11/4/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1700</qty>
    <amount>68</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4863</txnID>
    <date>11/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>2000</qty>
    <amount>1840</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4864</txnID>
    <date>6/1/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4865</txnID>
    <date>11/12/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4866</txnID>
    <date>2/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4867</txnID>
    <date>7/22/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4868</txnID>
    <date>11/26/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4869</txnID>
    <date>2/9/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Diaprogenix</prod>
    <qty>300</qty>
    <amount>12</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4870</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4871</txnID>
    <date>1/28/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>2000</qty>
    <amount>7740</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4872</txnID>
    <date>10/17/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4873</txnID>
    <date>2/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Bhiktarvizem</prod>
    <qty>600</qty>
    <amount>2322</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4874</txnID>
    <date>2/11/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4875</txnID>
    <date>10/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Alaraphosol</prod>
    <qty>1200</qty>
    <amount>1104</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4876</txnID>
    <date>4/26/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4877</txnID>
    <date>11/9/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4878</txnID>
    <date>4/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1900</qty>
    <amount>2337</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4879</txnID>
    <date>8/19/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1400</qty>
    <amount>2016</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4880</txnID>
    <date>2/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>2000</qty>
    <amount>7740</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4881</txnID>
    <date>8/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>900</qty>
    <amount>648</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4882</txnID>
    <date>6/3/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4883</txnID>
    <date>6/21/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Colophrazen</prod>
    <qty>200</qty>
    <amount>246</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4884</txnID>
    <date>3/12/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Clobromizen</prod>
    <qty>1700</qty>
    <amount>2448</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4885</txnID>
    <date>3/9/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1000</qty>
    <amount>3870</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4886</txnID>
    <date>11/18/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4887</txnID>
    <date>5/23/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4888</txnID>
    <date>1/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4889</txnID>
    <date>10/20/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>900</qty>
    <amount>2538</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4890</txnID>
    <date>10/11/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4891</txnID>
    <date>10/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4892</txnID>
    <date>5/19/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Diaprogenix</prod>
    <qty>1100</qty>
    <amount>44</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4893</txnID>
    <date>5/28/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4894</txnID>
    <date>1/16/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1500</qty>
    <amount>2805</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4895</txnID>
    <date>8/17/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>600</qty>
    <amount>552</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4896</txnID>
    <date>6/9/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>700</qty>
    <amount>1974</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4897</txnID>
    <date>1/4/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1500</qty>
    <amount>1380</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4898</txnID>
    <date>8/8/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>700</qty>
    <amount>644</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4899</txnID>
    <date>12/21/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>1400</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4900</txnID>
    <date>7/21/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>700</qty>
    <amount>1309</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4901</txnID>
    <date>8/5/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>200</qty>
    <amount>774</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4902</txnID>
    <date>9/5/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4903</txnID>
    <date>7/7/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>500</qty>
    <amount>360</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4904</txnID>
    <date>10/1/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4905</txnID>
    <date>10/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>800</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4906</txnID>
    <date>4/10/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4907</txnID>
    <date>6/12/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>200</qty>
    <amount>8</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4908</txnID>
    <date>8/23/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1500</qty>
    <amount>2160</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4909</txnID>
    <date>4/9/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4910</txnID>
    <date>5/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4911</txnID>
    <date>6/11/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Colophrazen</prod>
    <qty>500</qty>
    <amount>615</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4912</txnID>
    <date>7/22/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4913</txnID>
    <date>5/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1900</qty>
    <amount>3553</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4914</txnID>
    <date>8/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4915</txnID>
    <date>12/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>2000</qty>
    <amount>5640</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4916</txnID>
    <date>3/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>1100</qty>
    <amount>1584</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4917</txnID>
    <date>2/3/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>400</qty>
    <amount>368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4918</txnID>
    <date>7/7/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4919</txnID>
    <date>12/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1300</qty>
    <amount>2431</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4920</txnID>
    <date>10/2/2020</date>
    <cust>Enim PC</cust>
    <prod>Xinoprozen</prod>
    <qty>600</qty>
    <amount>1692</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4921</txnID>
    <date>5/17/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4922</txnID>
    <date>4/12/2020</date>
    <cust>Enim PC</cust>
    <prod>Diaprogenix</prod>
    <qty>1900</qty>
    <amount>76</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4923</txnID>
    <date>6/7/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xinoprozen</prod>
    <qty>800</qty>
    <amount>2256</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4924</txnID>
    <date>2/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4925</txnID>
    <date>11/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4926</txnID>
    <date>11/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>100</qty>
    <amount>92</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4927</txnID>
    <date>4/5/2020</date>
    <cust>Enim PC</cust>
    <prod>Clobromizen</prod>
    <qty>1000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4928</txnID>
    <date>11/13/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xipramin</prod>
    <qty>2000</qty>
    <amount>1440</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4929</txnID>
    <date>11/9/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4930</txnID>
    <date>10/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Clobromizen</prod>
    <qty>1200</qty>
    <amount>1728</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4931</txnID>
    <date>6/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4932</txnID>
    <date>9/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>500</qty>
    <amount>460</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4933</txnID>
    <date>3/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4934</txnID>
    <date>10/6/2020</date>
    <cust>Erat Pharma</cust>
    <prod>Xipramin</prod>
    <qty>1900</qty>
    <amount>1368</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4935</txnID>
    <date>5/1/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1600</qty>
    <amount>1472</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4936</txnID>
    <date>5/8/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4937</txnID>
    <date>4/8/2020</date>
    <cust>Enim PC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4938</txnID>
    <date>2/5/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Xinoprozen</prod>
    <qty>1000</qty>
    <amount>2820</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4939</txnID>
    <date>10/23/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Bhiktarvizem</prod>
    <qty>400</qty>
    <amount>1548</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4940</txnID>
    <date>2/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xipramin</prod>
    <qty>1600</qty>
    <amount>1152</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4941</txnID>
    <date>8/19/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Colophrazen</prod>
    <qty>1500</qty>
    <amount>1845</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4942</txnID>
    <date>1/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4943</txnID>
    <date>7/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Colophrazen</prod>
    <qty>800</qty>
    <amount>984</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4944</txnID>
    <date>4/27/2020</date>
    <cust>Varius Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4945</txnID>
    <date>4/2/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1200</qty>
    <amount>48</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4946</txnID>
    <date>8/18/2020</date>
    <cust>Varius Plc</cust>
    <prod>Colophrazen</prod>
    <qty>1300</qty>
    <amount>1599</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4947</txnID>
    <date>5/15/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Alaraphosol</prod>
    <qty>1700</qty>
    <amount>1564</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4948</txnID>
    <date>2/4/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Diaprogenix</prod>
    <qty>1000</qty>
    <amount>40</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4949</txnID>
    <date>5/8/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>800</qty>
    <amount>32</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4950</txnID>
    <date>3/17/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xipramin</prod>
    <qty>800</qty>
    <amount>576</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4951</txnID>
    <date>5/4/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1900</qty>
    <amount>1748</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4952</txnID>
    <date>5/14/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Colophrazen</prod>
    <qty>1700</qty>
    <amount>2091</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4953</txnID>
    <date>3/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4954</txnID>
    <date>10/5/2020</date>
    <cust>Varius Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>300</qty>
    <amount>276</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4955</txnID>
    <date>11/6/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>1500</qty>
    <amount>60</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4956</txnID>
    <date>3/16/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Xinoprozen</prod>
    <qty>1900</qty>
    <amount>5358</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4957</txnID>
    <date>8/22/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4958</txnID>
    <date>11/15/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4959</txnID>
    <date>5/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1200</qty>
    <amount>2244</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4960</txnID>
    <date>9/14/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Clobromizen</prod>
    <qty>100</qty>
    <amount>144</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4961</txnID>
    <date>8/13/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Colophrazen</prod>
    <qty>1000</qty>
    <amount>1230</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4962</txnID>
    <date>2/18/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4963</txnID>
    <date>8/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Clobromizen</prod>
    <qty>700</qty>
    <amount>1008</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4964</txnID>
    <date>1/26/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4965</txnID>
    <date>1/4/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4966</txnID>
    <date>8/3/2020</date>
    <cust>Lorem Luctus</cust>
    <prod>Diaprogenix</prod>
    <qty>900</qty>
    <amount>36</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4967</txnID>
    <date>1/19/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1100</qty>
    <amount>4257</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4968</txnID>
    <date>11/18/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xinoprozen</prod>
    <qty>1600</qty>
    <amount>4512</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4969</txnID>
    <date>7/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Colophrazen</prod>
    <qty>300</qty>
    <amount>369</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4970</txnID>
    <date>2/22/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4971</txnID>
    <date>8/10/2020</date>
    <cust>Varius Plc</cust>
    <prod>Bhiktarvizem</prod>
    <qty>1800</qty>
    <amount>6966</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4972</txnID>
    <date>5/4/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4973</txnID>
    <date>2/3/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Bhiktarvizem</prod>
    <qty>700</qty>
    <amount>2709</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4974</txnID>
    <date>11/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1800</qty>
    <amount>72</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4975</txnID>
    <date>6/23/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1200</qty>
    <amount>3384</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4976</txnID>
    <date>4/26/2020</date>
    <cust>Eu Dolor Companie</cust>
    <prod>Colophrazen</prod>
    <qty>600</qty>
    <amount>738</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4977</txnID>
    <date>9/24/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>1100</qty>
    <amount>3102</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4978</txnID>
    <date>11/10/2020</date>
    <cust>Eastern Hospital Group</cust>
    <prod>Xinoprozen</prod>
    <qty>1500</qty>
    <amount>4230</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4979</txnID>
    <date>12/16/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Alaraphosol</prod>
    <qty>200</qty>
    <amount>184</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4980</txnID>
    <date>3/20/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Clobromizen</prod>
    <qty>200</qty>
    <amount>288</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4981</txnID>
    <date>10/20/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>1600</qty>
    <amount>64</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4982</txnID>
    <date>11/3/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Alaraphosol</prod>
    <qty>1000</qty>
    <amount>920</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4983</txnID>
    <date>5/15/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Diaprogenix</prod>
    <qty>500</qty>
    <amount>20</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4984</txnID>
    <date>7/25/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>500</qty>
    <amount>935</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4985</txnID>
    <date>2/14/2020</date>
    <cust>Plaxus Medical</cust>
    <prod>Xipramin</prod>
    <qty>1500</qty>
    <amount>1080</amount>
    <country>USA</country>
    <repID>119</repID>
  </txn>
  <txn>
    <txnID>4986</txnID>
    <date>5/8/2020</date>
    <cust>Varius Plc</cust>
    <prod>Clobromizen</prod>
    <qty>900</qty>
    <amount>1296</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4987</txnID>
    <date>2/24/2020</date>
    <cust>Varius Plc</cust>
    <prod>Diaprogenix</prod>
    <qty>600</qty>
    <amount>24</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4988</txnID>
    <date>1/10/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Xinoprozen</prod>
    <qty>200</qty>
    <amount>564</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4989</txnID>
    <date>3/10/2020</date>
    <cust>Adipiscing Mauris Inc.</cust>
    <prod>Xipramin</prod>
    <qty>700</qty>
    <amount>504</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4990</txnID>
    <date>3/17/2020</date>
    <cust>Vitae Risus Incorporated</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>USA</country>
    <repID>203</repID>
  </txn>
  <txn>
    <txnID>4991</txnID>
    <date>2/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Xipramin</prod>
    <qty>1100</qty>
    <amount>792</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4992</txnID>
    <date>3/5/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Alaraphosol</prod>
    <qty>1400</qty>
    <amount>1288</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4993</txnID>
    <date>6/26/2020</date>
    <cust>Proin Dolor Institut</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1100</qty>
    <amount>2057</amount>
    <country>Germany</country>
    <repID>221</repID>
  </txn>
  <txn>
    <txnID>4994</txnID>
    <date>3/9/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>300</qty>
    <amount>561</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
  <txn>
    <txnID>4995</txnID>
    <date>8/2/2020</date>
    <cust>Nisl Quisque</cust>
    <prod>Xinoprozen</prod>
    <qty>1400</qty>
    <amount>3948</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4996</txnID>
    <date>10/11/2020</date>
    <cust>Luctus Aliquet Plc</cust>
    <prod>Alaraphosol</prod>
    <qty>1800</qty>
    <amount>1656</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4997</txnID>
    <date>11/12/2020</date>
    <cust>Varius Plc</cust>
    <prod>Gerantrazeophem</prod>
    <qty>1400</qty>
    <amount>2618</amount>
    <country>Brazil</country>
    <repID>887</repID>
  </txn>
  <txn>
    <txnID>4998</txnID>
    <date>6/11/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Diaprogenix</prod>
    <qty>100</qty>
    <amount>4</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>4999</txnID>
    <date>3/9/2020</date>
    <cust>At Pretium LLC</cust>
    <prod>Gerantrazeophem</prod>
    <qty>400</qty>
    <amount>748</amount>
    <country>USA</country>
    <repID>332</repID>
  </txn>
  <txn>
    <txnID>5000</txnID>
    <date>6/2/2020</date>
    <cust>Eleifend GMBH</cust>
    <prod>Gerantrazeophem</prod>
    <qty>800</qty>
    <amount>1496</amount>
    <country>Germany</country>
    <repID>100</repID>
  </txn>
</txns>
